KR102659019B1 - Synthesis method of sex pheromon cis-7,8-epoxy-2-methyloctadecane in Lymantria dispar - Google Patents
Synthesis method of sex pheromon cis-7,8-epoxy-2-methyloctadecane in Lymantria dispar Download PDFInfo
- Publication number
- KR102659019B1 KR102659019B1 KR1020220112069A KR20220112069A KR102659019B1 KR 102659019 B1 KR102659019 B1 KR 102659019B1 KR 1020220112069 A KR1020220112069 A KR 1020220112069A KR 20220112069 A KR20220112069 A KR 20220112069A KR 102659019 B1 KR102659019 B1 KR 102659019B1
- Authority
- KR
- South Korea
- Prior art keywords
- cis
- tetradec
- methyloctadecane
- epoxy
- synthesizing
- Prior art date
Links
- 241000721703 Lymantria dispar Species 0.000 title claims abstract description 35
- HFOFYNMWYRXIBP-MOPGFXCFSA-N 2-methyl-7S,8R-Epoxy-octadecane Chemical compound CCCCCCCCCC[C@H]1O[C@H]1CCCCC(C)C HFOFYNMWYRXIBP-MOPGFXCFSA-N 0.000 title claims abstract description 33
- 238000001308 synthesis method Methods 0.000 title claims abstract description 9
- XDBKLFODBADBED-YPKPFQOOSA-N (z)-2-methyloctadec-7-ene Chemical compound CCCCCCCCCC\C=C/CCCCC(C)C XDBKLFODBADBED-YPKPFQOOSA-N 0.000 claims abstract description 30
- 230000002194 synthesizing effect Effects 0.000 claims abstract description 30
- MDMMHGIVSNOJID-UHFFFAOYSA-N tetradec-3-yn-1-ol Chemical compound CCCCCCCCCCC#CCCO MDMMHGIVSNOJID-UHFFFAOYSA-N 0.000 claims abstract description 26
- OTJZCIYGRUNXTP-UHFFFAOYSA-N but-3-yn-1-ol Chemical compound OCCC#C OTJZCIYGRUNXTP-UHFFFAOYSA-N 0.000 claims abstract description 21
- 239000000877 Sex Attractant Substances 0.000 claims abstract description 20
- 238000000034 method Methods 0.000 claims abstract description 18
- 238000003747 Grignard reaction Methods 0.000 claims abstract description 13
- 239000003054 catalyst Substances 0.000 claims abstract description 13
- WJGVYRMMIIWBAU-UHFFFAOYSA-M magnesium;2-methylbutane;bromide Chemical compound [Mg+2].[Br-].CC(C)C[CH2-] WJGVYRMMIIWBAU-UHFFFAOYSA-M 0.000 claims abstract description 8
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims description 51
- 238000003756 stirring Methods 0.000 claims description 49
- 239000002904 solvent Substances 0.000 claims description 47
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 39
- 238000006243 chemical reaction Methods 0.000 claims description 37
- 238000000605 extraction Methods 0.000 claims description 27
- 239000012044 organic layer Substances 0.000 claims description 22
- 125000006239 protecting group Chemical group 0.000 claims description 21
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 16
- YSKSITWWXKYFHK-UHFFFAOYSA-N 2-tetradec-3-ynoxyoxane Chemical compound CCCCCCCCCCC#CCCOC1CCCCO1 YSKSITWWXKYFHK-UHFFFAOYSA-N 0.000 claims description 14
- 239000000203 mixture Substances 0.000 claims description 13
- MYMSJFSOOQERIO-UHFFFAOYSA-N 1-bromodecane Chemical compound CCCCCCCCCCBr MYMSJFSOOQERIO-UHFFFAOYSA-N 0.000 claims description 12
- JOXIMZWYDAKGHI-UHFFFAOYSA-M toluene-4-sulfonate Chemical compound CC1=CC=C(S([O-])(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-M 0.000 claims description 12
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 claims description 12
- 239000007864 aqueous solution Substances 0.000 claims description 11
- 238000002156 mixing Methods 0.000 claims description 9
- YYROPELSRYBVMQ-UHFFFAOYSA-N 4-toluenesulfonyl chloride Chemical compound CC1=CC=C(S(Cl)(=O)=O)C=C1 YYROPELSRYBVMQ-UHFFFAOYSA-N 0.000 claims description 8
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 claims description 8
- 238000005406 washing Methods 0.000 claims description 8
- PIICEJLVQHRZGT-UHFFFAOYSA-N Ethylenediamine Chemical compound NCCN PIICEJLVQHRZGT-UHFFFAOYSA-N 0.000 claims description 6
- 239000001257 hydrogen Substances 0.000 claims description 5
- 229910052739 hydrogen Inorganic materials 0.000 claims description 5
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 4
- 229910000030 sodium bicarbonate Inorganic materials 0.000 claims description 4
- 235000017557 sodium bicarbonate Nutrition 0.000 claims description 4
- 239000012141 concentrate Substances 0.000 claims description 3
- HFOFYNMWYRXIBP-UHFFFAOYSA-N 2-decyl-3-(5-methylhexyl)oxirane Chemical compound CCCCCCCCCCC1OC1CCCCC(C)C HFOFYNMWYRXIBP-UHFFFAOYSA-N 0.000 abstract description 9
- 241000721696 Lymantria Species 0.000 abstract description 9
- 239000003016 pheromone Substances 0.000 abstract description 8
- 241000607479 Yersinia pestis Species 0.000 abstract description 6
- 238000010531 catalytic reduction reaction Methods 0.000 abstract description 5
- 239000007858 starting material Substances 0.000 abstract description 5
- 238000005984 hydrogenation reaction Methods 0.000 abstract description 4
- 238000006735 epoxidation reaction Methods 0.000 abstract description 3
- 239000000126 substance Substances 0.000 abstract description 3
- 239000004593 Epoxy Substances 0.000 abstract description 2
- 239000005667 attractant Substances 0.000 abstract description 2
- 230000031902 chemoattractant activity Effects 0.000 abstract description 2
- 239000000575 pesticide Substances 0.000 abstract description 2
- 238000006722 reduction reaction Methods 0.000 abstract 1
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 42
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 34
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 25
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 20
- 238000005481 NMR spectroscopy Methods 0.000 description 15
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 15
- 230000015572 biosynthetic process Effects 0.000 description 14
- 239000000741 silica gel Substances 0.000 description 14
- 229910002027 silica gel Inorganic materials 0.000 description 14
- 238000003786 synthesis reaction Methods 0.000 description 14
- 238000004809 thin layer chromatography Methods 0.000 description 14
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 12
- MZRVEZGGRBJDDB-UHFFFAOYSA-N N-Butyllithium Chemical compound [Li]CCCC MZRVEZGGRBJDDB-UHFFFAOYSA-N 0.000 description 11
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 11
- ZQZSNKJFOFAJQX-UHFFFAOYSA-N 2-but-3-ynoxyoxane Chemical compound C#CCCOC1CCCCO1 ZQZSNKJFOFAJQX-UHFFFAOYSA-N 0.000 description 10
- 239000011780 sodium chloride Substances 0.000 description 10
- NHQDETIJWKXCTC-UHFFFAOYSA-N 3-chloroperbenzoic acid Chemical compound OOC(=O)C1=CC=CC(Cl)=C1 NHQDETIJWKXCTC-UHFFFAOYSA-N 0.000 description 9
- 150000001875 compounds Chemical class 0.000 description 9
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 8
- GNOIPBMMFNIUFM-UHFFFAOYSA-N hexamethylphosphoric triamide Chemical compound CN(C)P(=O)(N(C)C)N(C)C GNOIPBMMFNIUFM-UHFFFAOYSA-N 0.000 description 7
- 238000005160 1H NMR spectroscopy Methods 0.000 description 6
- 239000007818 Grignard reagent Substances 0.000 description 5
- 241000255777 Lepidoptera Species 0.000 description 5
- 150000004795 grignard reagents Chemical class 0.000 description 5
- 102100039148 Ankyrin repeat domain-containing protein 49 Human genes 0.000 description 4
- 101000889457 Homo sapiens Ankyrin repeat domain-containing protein 49 Proteins 0.000 description 4
- 238000001914 filtration Methods 0.000 description 4
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 4
- 241000894007 species Species 0.000 description 4
- YXZFFTJAHVMMLF-UHFFFAOYSA-N 1-bromo-3-methylbutane Chemical compound CC(C)CCBr YXZFFTJAHVMMLF-UHFFFAOYSA-N 0.000 description 3
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 3
- 229910021591 Copper(I) chloride Inorganic materials 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- 241001124557 Lymantriidae Species 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- 239000003153 chemical reaction reagent Substances 0.000 description 3
- 229940125782 compound 2 Drugs 0.000 description 3
- 229940126214 compound 3 Drugs 0.000 description 3
- 229940125898 compound 5 Drugs 0.000 description 3
- OXBLHERUFWYNTN-UHFFFAOYSA-M copper(I) chloride Chemical compound [Cu]Cl OXBLHERUFWYNTN-UHFFFAOYSA-M 0.000 description 3
- 238000010438 heat treatment Methods 0.000 description 3
- 229910052763 palladium Inorganic materials 0.000 description 3
- 238000000746 purification Methods 0.000 description 3
- ZDYVRSLAEXCVBX-UHFFFAOYSA-N pyridinium p-toluenesulfonate Chemical compound C1=CC=[NH+]C=C1.CC1=CC=C(S([O-])(=O)=O)C=C1 ZDYVRSLAEXCVBX-UHFFFAOYSA-N 0.000 description 3
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 2
- BUDQDWGNQVEFAC-UHFFFAOYSA-N Dihydropyran Chemical compound C1COC=CC1 BUDQDWGNQVEFAC-UHFFFAOYSA-N 0.000 description 2
- DHXVGJBLRPWPCS-UHFFFAOYSA-N Tetrahydropyran Chemical compound C1CCOCC1 DHXVGJBLRPWPCS-UHFFFAOYSA-N 0.000 description 2
- 238000004587 chromatography analysis Methods 0.000 description 2
- 235000013399 edible fruits Nutrition 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 230000013011 mating Effects 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- XAOFMTDKQYEOES-UHFFFAOYSA-N 1-bromo-5-methylhexane Chemical compound CC(C)CCCCBr XAOFMTDKQYEOES-UHFFFAOYSA-N 0.000 description 1
- JIUFYGIESXPUPL-UHFFFAOYSA-N 5-methylhex-1-ene Chemical compound CC(C)CCC=C JIUFYGIESXPUPL-UHFFFAOYSA-N 0.000 description 1
- 241000022586 Erebidae Species 0.000 description 1
- 241000238631 Hexapoda Species 0.000 description 1
- 241000337464 Lymantria dispar asiatica Species 0.000 description 1
- 241000701409 Lymantria dispar multiple nucleopolyhedrovirus Species 0.000 description 1
- 241000256259 Noctuidae Species 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 241000219492 Quercus Species 0.000 description 1
- 101710129069 Serine/threonine-protein phosphatase 5 Proteins 0.000 description 1
- 101710199542 Serine/threonine-protein phosphatase T Proteins 0.000 description 1
- YZCKVEUIGOORGS-NJFSPNSNSA-N Tritium Chemical compound [3H] YZCKVEUIGOORGS-NJFSPNSNSA-N 0.000 description 1
- 235000019270 ammonium chloride Nutrition 0.000 description 1
- 238000004891 communication Methods 0.000 description 1
- 229940125904 compound 1 Drugs 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000035613 defoliation Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- SZSMWWNXCCLLEK-UHFFFAOYSA-N dhp 3,4-dihydro-2h-pyran Chemical compound C1COC=CC1.C1COC=CC1 SZSMWWNXCCLLEK-UHFFFAOYSA-N 0.000 description 1
- IJKVHSBPTUYDLN-UHFFFAOYSA-N dihydroxy(oxo)silane Chemical compound O[Si](O)=O IJKVHSBPTUYDLN-UHFFFAOYSA-N 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- ZVDBUOGYYYNMQI-UHFFFAOYSA-N dodec-1-yne Chemical compound CCCCCCCCCCC#C ZVDBUOGYYYNMQI-UHFFFAOYSA-N 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 230000007614 genetic variation Effects 0.000 description 1
- 150000002431 hydrogen Chemical class 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 230000007803 itching Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 238000000655 nuclear magnetic resonance spectrum Methods 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 238000000053 physical method Methods 0.000 description 1
- 229920000470 poly(p-phenylene terephthalate) polymer Polymers 0.000 description 1
- 230000003389 potentiating effect Effects 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000012552 review Methods 0.000 description 1
- 230000001568 sexual effect Effects 0.000 description 1
- 239000012279 sodium borohydride Substances 0.000 description 1
- 229910000033 sodium borohydride Inorganic materials 0.000 description 1
- 238000010189 synthetic method Methods 0.000 description 1
- 229910052722 tritium Inorganic materials 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
- C07D303/02—Compounds containing oxirane rings
- C07D303/04—Compounds containing oxirane rings containing only hydrogen and carbon atoms in addition to the ring oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D301/00—Preparation of oxiranes
- C07D301/02—Synthesis of the oxirane ring
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
본 발명은 매미나방의 성페로몬인 시스-7,8-에폭시-2-메틸옥타데칸의 합성방법에 관한 것으로, 특히 3-부틴올을 출발물질로 사용하고 Ni(OAc)2 를 촉매로 사용한 촉매환원 반응과 그리냐르 반응으로 매미나방 페로몬인 시스-7,8-에폭시-2-메틸옥타데칸을 대량으로 합성하는 방법에 관한 것이다. 본 발명의 합성방법은, (a) 3-부틴올로부터 테트라덱-3-인-1-올을 합성하는 단계; (b) Ni(oAc)2 촉매 하에 부분 수소화 반응시켜 시스-테트라덱-3-엔-1-올을 합성하는 단계; (c) 이소펜틸마그네슘 브로마이드로 그리냐르 반응시켜 시스-2-메틸옥타덱-7-엔을 합성하는 단계; 및 (d) 에폭시화 반응시켜 시스-7,8-에폭시-2-메틸옥타데칸을 합성하는 단계를 포함한다. 본 발명은, 출발물질로 3-부틴올을 사용하고 고가의 Pd 대신 저가의 Ni(OAc)2 를 촉매로 사용한 촉매환원 반응과 그리냐르 반응으로, 매미나방 성페로몬인 시스-7,8-에폭시-2-메틸옥타데칸을 대량 합성할 수 있다. 본 발명에 따라 합성된 7,8-에폭시-2-메틸옥타데칸은 매미나방 성페로몬을 이용한 트랩에 유인제로 사용하여 야외에서 매미나방의 발생여부를 보다 쉽게 예찰할 수 있고, 이를 바탕으로 농가 등에 대량으로 포획트랩을 보급함으로써 화학농약을 사용하지 않는 환경친화적인 방법으로 해충인 매미나방을 방제할 수 있다.The present invention relates to a method for synthesizing cis-7,8-epoxy-2-methyloctadecane, a sex pheromone of the gypsy moth, in particular using 3-butynol as a starting material and Ni(OAc) 2 as a catalyst. This relates to a method for mass synthesizing cis-7,8-epoxy-2-methyloctadecane, a gypsy moth pheromone, through reduction and Grignard reactions. The synthesis method of the present invention includes (a) synthesizing tetradec-3-yn-1-ol from 3-butynol; (b) synthesizing cis-tetradec-3-en-1-ol by partial hydrogenation under Ni(oAc) 2 catalyst; (c) synthesizing cis-2-methyloctadec-7-ene through Grignard reaction with isopentylmagnesium bromide; and (d) an epoxidation reaction to synthesize cis-7,8-epoxy-2-methyloctadecane. The present invention uses 3-butynol as a starting material and a catalytic reduction reaction and Grignard reaction using inexpensive Ni(OAc) 2 instead of expensive Pd as a catalyst to produce cis-7,8-epoxy, a gypsy moth sex pheromone. -2-Methyloctadecane can be synthesized in large quantities. 7,8-Epoxy-2-methyloctadecane synthesized according to the present invention can be used as an attractant in traps using gypsy moth sex pheromone to more easily monitor the occurrence of gypsy moths outdoors, and based on this, it can be used in farms, etc. By distributing traps in large quantities, it is possible to control the pest gypsy moth in an environmentally friendly way that does not use chemical pesticides.
Description
본 발명은 매미나방의 성페로몬인 시스-7,8-에폭시-2-메틸옥타데칸의 합성방법에 관한 것으로, 보다 상세하게는 3-부틴올을 출발물질로 사용하고 Ni(OAc)2 를 촉매로 사용한 촉매환원 반응과 그리냐르 반응으로 매미나방 페로몬인 시스-7,8-에폭시-2-메틸옥타데칸을 대량으로 합성하는 방법에 관한 것이다.The present invention relates to a method for synthesizing cis-7,8-epoxy-2-methyloctadecane, a sex pheromone of the gypsy moth, and more specifically, using 3-butynol as a starting material and Ni(OAc) 2 as a catalyst. This relates to a method for mass synthesizing cis-7,8-epoxy-2-methyloctadecane, a gypsy moth pheromone, using catalytic reduction reaction and Grignard reaction.
매미나방(Lymantria dispar, Gypsy moth)은 나비목 독나방과에 속하는 종으로 전 세계적으로 가장 피해를 많이 주는 산림해충이다(Leonard, 1974). 한국을 포함한 아시아와 유럽이 원산이나, 북미지역으로 유입되어 참나무류에 큰 피해를 주는 해충이기도 하다(Pogue and Schaefer, 2007; GBIF Secretariat, 2019). 국내에서도 대량발생하여 국지적인 수준에서 피해를 준 사례가 있었다. 특히 2020년에는 전라권역을 제외한 거의 모든 지역에서 19종의 과수 및 수목에 대량발생하여 10개 시도, 6183ha에 피해를 주었다(Jung et al., 2020). 특히, 겨울철 이상고온현상으로 인하여 매미나방의 월동치사율이 낮아지면서 매미나방의 발생이 증가하고 있다. The gypsy moth ( Lymantria dispar , Gypsy moth) is a species belonging to the Lepidoptera family Mothidae and is the most damaging forest pest worldwide (Leonard, 1974). It is native to Asia and Europe, including Korea, but is also a pest that has been introduced into North America and causes great damage to oak trees (Pogue and Schaefer, 2007; GBIF Secretariat, 2019). There have been cases in Korea where large-scale outbreaks occurred and caused damage at a local level. In particular, in 2020, it occurred in large numbers in 19 types of fruit trees and trees in almost all regions except the Jeolla region, causing damage to 6,183 ha in 10 cities and provinces (Jung et al., 2020). In particular, the winter mortality rate of gypsy moths is decreasing due to abnormally high temperatures in winter, and the occurrence of gypsy moths is increasing.
매미나방은 산림에 피해를 입힐 뿐 아니라 산림 인근지역의 도심공원에도 유충과 나방이 대량발생하여 매미나방의 애벌레가 사람에게도 피부가려움증과 혐오감을 유발함으로써 도시민에게도 피해를 끼치고 있다. 또한 매미나방이 발생한 산림 주변의 농경지로 매미나방이 유입하는 빈도가 높아지면서 과수 등 농작물에도 피해가 예상된다. 따라서 매미나방의 도발적 발생에 대한 예찰분석 및 종합적 방제대책이 절실하다(Hwang ea al., 2021).Gypsy moths not only cause damage to forests, but also cause large numbers of larvae and moths to appear in urban parks near forests, causing damage to city residents by causing skin itching and disgust in humans. In addition, as the frequency of gypsy moths entering farmland around forests where gypsy moths occur increases, damage to crops such as fruit trees is expected. Therefore, predictive analysis and comprehensive control measures for provocative outbreaks of gypsy moth are urgently needed (Hwang et al., 2021).
매미나방의 성유인페로몬은 시스-7,8-에폭시-2-메틸옥타데칸{cis-7,8-epoxy-2-methyloctadecane; (±)-Disparlure}으로 동정되었고, 광학이성질체인 (+)-거울상이성질체{(+)-Enantiomer} 또는 (-)-디스파루어{(-)-Disparlure}가 성유인에 관여하는 것으로 밝혀졌다(Bierl et al. 1970, Iwaki 1974). The sex attractant pheromone of the gypsy moth is cis-7,8-epoxy-2-methyloctadecane {cis-7,8-epoxy-2-methyloctadecane; (±)-Disparlure}, and the optical isomer (+)-enantiomer {(+)-Enantiomer} or (-)-Disparlure{(-)-Disparlure} was found to be involved in sexual attraction. (Bierl et al. 1970, Iwaki 1974).
특히 페로몬은 동종간의 통신수단으로 숙주특이성이 있으므로 이를 이용하여 생태친화적인 방법으로 해충을 방제하는 기술에 대해 관심이 모아지고 있다. 매미나방의 합성페로몬인 디스파루어(disparlure)는 유인효과가 우수하기 때문에 밀도예찰(Tayler et al. 1991. Cater et al. 1994), 교미교란(Leonhardt et al. 1996) 등 방제를 목적으로 사용되고 있다. In particular, pheromones are a means of communication between species and are host-specific, so there is growing interest in technologies that use them to control pests in an ecologically friendly manner. Disparlure, a synthetic pheromone of the gypsy moth, has an excellent attraction effect and is therefore used for control purposes such as density monitoring (Tayler et al. 1991. Cater et al. 1994) and mating disturbance (Leonhardt et al. 1996). there is.
종래 시스-7,8-에폭시-2-메틸옥타데칸을 합성하는 공지된 합성방법은 다음과 같다(Sheads et al. 1973). The known synthetic method for synthesizing cis-7,8-epoxy-2-methyloctadecane is as follows (Sheads et al. 1973).
먼저 5-메틸 1-헥센(5-methyl 1-hexene)을 브롬화(bromination)시키고 1-도데킨(1-dodecyne)을 1-브로모-5-메틸헥산(1-bromo-5-methyl hexane)과 커플링(coupling)한 후 팔라듐(Pd) 촉매로 환원시켜 Z-2-메틸-7-옥타데켄(Z-2-methyl-7-octadecene)을 합성한다. 마지막으로 에폭시화하여 목적화합물인 시스-7,8-에폭시-2-메틸옥타데칸{(±)-디스파루어} 을 합성한다. 이 합성법의 핵심은 팔라듐(Pd) 촉매를 사용하여 삼중결합을 (Z)이중결합으로 환원하는 과정이다. 삼중결합을 촉매환원(catalytic redution)에 의하여 이중결합으로 환원시키는 반응은 일반적으로 트랜스(trans) 이성질체를 수반하게 된다. 따라서 원래의 (Z)이성질체의 생성비율을 90% 이상 만들기 쉽지 않고 두 이성질체를 물리적인 방법으로 분리하기도 쉽지 않은 문제점이 있다. 또한 (Z)선택성을 위하여 촉매로 사용되는 팔라듐(Pd)의 가격이 비싸고 반응의 재현성이 좋지 않다는 문제점이 있다. First, 5-methyl 1-hexene is brominated and 1-dodecyne is converted into 1-bromo-5-methyl hexane. After coupling, it is reduced with a palladium (Pd) catalyst to synthesize Z-2-methyl-7-octadecene. Finally, epoxidation is performed to synthesize the target compound, cis-7,8-epoxy-2-methyloctadecane {(±)-disparure}. The core of this synthesis method is the process of reducing a triple bond to a (Z) double bond using a palladium (Pd) catalyst. The reaction of reducing a triple bond to a double bond by catalytic reduction generally involves trans isomerism. Therefore, there is a problem that it is not easy to make the production rate of the original (Z) isomer more than 90% and it is not easy to separate the two isomers by physical methods. In addition, there is a problem that palladium (Pd), which is used as a catalyst for (Z) selectivity, is expensive and the reproducibility of the reaction is poor.
본 발명에서는 3-부틴올을 출발물질로 사용하고, 고가의 Pd 대신 저가의 Ni(OAc)2 를 촉매로 사용한 촉매환원 반응과 그리냐르 반응으로 매미나방의 성페로몬인 시스-7,8-에폭시-2-메틸옥타데칸을 대량으로 합성하는 방법을 제공하는 것을 목적으로 한다. In the present invention, 3-butynol is used as a starting material, and cis-7,8-epoxy, the sex pheromone of the gypsy moth, is produced through a catalytic reduction reaction and Grignard reaction using inexpensive Ni(OAc) 2 instead of expensive Pd as a catalyst. The purpose is to provide a method for synthesizing -2-methyloctadecane in large quantities.
상기 목적을 달성하기 위하여, 본 발명에서는,In order to achieve the above object, in the present invention,
(a) 3-부틴올의 -OH기에 보호기를 도입하고 1-할로데칸과 반응시킨 후 보호기를 제거하여 테트라덱-3-인-1-올을 합성하는 단계;(a) synthesizing tetradec-3-yn-1-ol by introducing a protecting group into the -OH group of 3-butynol, reacting it with 1-halodecane, and then removing the protecting group;
(b) 테트라덱-3-인-1-올을 Ni(oAc)2 촉매 하에 부분 수소화 반응시켜 시스-테트라덱-3-엔-1-올을 합성하는 단계;(b) synthesizing cis-tetradec-3-en-1-ol by partial hydrogenation of tetradec-3-yn-1-ol under a Ni(oAc) 2 catalyst;
(c) 시스-테트라덱-3-엔-1-올의 -OH기를 토실레이트화 한 후 이소펜틸마그네슘 브로마이드로 그리냐르 반응시켜 시스-2-메틸옥타덱-7-엔을 합성하는 단계; 및(c) synthesizing cis-2-methyloctadec-7-ene by tosylating the -OH group of cis-tetradec-3-en-1-ol and then subjecting it to Grignard reaction with isopentylmagnesium bromide; and
(d) 시스-2-메틸옥타덱-7-엔을 에폭시화 반응시켜 시스-7,8-에폭시-2-메틸옥타데칸을 합성하는 단계를 포함하는, 매미나방의 성페로몬인 시스-7,8-에폭시-2-메틸옥타데칸의 합성방법을 제공한다.(d) cis-7, a sex pheromone of the gypsy moth, comprising the step of synthesizing cis-7,8-epoxy-2-methyloctadecane by epoxidizing cis-2-methyloctadec-7-ene, A method for synthesizing 8-epoxy-2-methyloctadecane is provided.
상기 합성방법에서, 상기 단계 (a)는, 바람직하게는 3-부틴올의 -OH기에 보호기를 도입하고 1-브로모데칸과 반응시킨 후 보호기를 제거하여 테트라덱-3-인-1-올을 합성한다. 상기 보호기는, 바람직하게는 -OTHP기이다. In the above synthesis method, step (a) is preferably performed by introducing a protecting group into the -OH group of 3-butynol, reacting it with 1-bromodecane, and then removing the protecting group to produce tetradec-3-yn-1-ol. synthesize. The protecting group is preferably -OTHP group.
상기 합성방법에서, 상기 보호기를 제거하는 공정은, 바람직하게는, In the above synthesis method, the step of removing the protecting group is preferably,
상기 1-브로모데칸과의 반응으로 얻어진 2-(테트라덱-3-인-1-일옥시)테트라하이드로-2H-피란을 용매인 메탄올에 용해시키는 단계;Dissolving 2-(tetradec-3-yn-1-yloxy)tetrahydro-2H-pyran obtained by reaction with 1-bromodecane in methanol as a solvent;
메탄올에 용해된 2-(테트라덱-3-인-1-일옥시)테트라하이드로-2H-피란과 p-톨루엔술폰산을 혼합하고 실온에서 3~6시간 동안 교반하면서 반응시키는 단계;Mixing 2-(tetradec-3-yn-1-yloxy)tetrahydro-2H-pyran and p-toluenesulfonic acid dissolved in methanol and reacting with stirring for 3 to 6 hours at room temperature;
상기 용매를 제거하는 단계;removing the solvent;
추출용매로 추출하는 단계;Extracting with an extraction solvent;
추출된 유기층을 세척 및 농축하는 단계; 및Washing and concentrating the extracted organic layer; and
농축된 잔여물을 정제하는 단계를 포함한다. and purifying the concentrated residue.
상기 합성방법에서, 상기 단계 (b)는 바람직하게는, In the above synthesis method, step (b) is preferably,
Ni(oAc)2와 NaBH4를 각각 용매 에탄올에 용해시키는 단계;Dissolving Ni(oAc) 2 and NaBH 4 in the solvent ethanol, respectively;
메탄올에 용해된 Ni(oAc)2와 NaBH4를 교반하면서 혼합하는 단계;Mixing Ni(oAc) 2 and NaBH 4 dissolved in methanol with stirring;
상기 혼합물에 에틸렌디아민과 테트라덱-3-인-1-올을 혼합하고 수소를 주입하여 실온에서 4~8시간 동안 교반하면서 반응시키는 단계;Mixing ethylenediamine and tetradec-3-yn-1-ol in the mixture, injecting hydrogen and reacting with stirring at room temperature for 4 to 8 hours;
상기 용매를 제거하는 단계;removing the solvent;
추출용매로 추출하는 단계;Extracting with an extraction solvent;
추출된 유기층을 세척 및 농축하는 단계; 및 Washing and concentrating the extracted organic layer; and
농축된 잔여물을 정제하는 단계를 포함한다. and purifying the concentrated residue.
상기 합성방법에서, 상기 단계 (c)는 바람직하게는, In the above synthesis method, step (c) is preferably,
시스-테트라덱-3-엔-1-올을 p-톨루엔설포닐 클로라이드와 반응시켜 시스-테트라덱-3-엔-1-일 4-메틸벤젠술포네이트를 합성한 후, 이소펜틸마그네슘 브로마이드로 그리냐르 반응시켜 시스-2-메틸옥타덱-7-엔을 합성한다. Cis-tetradec-3-en-1-ol was reacted with p-toluenesulfonyl chloride to synthesize cis-tetradec-3-en-1-yl 4-methylbenzenesulfonate, and then reacted with isopentylmagnesium bromide. Cis-2-methyloctadec-7-ene is synthesized through Grignard reaction.
상기 합성방법에서, 상기 단계 (d)는 바람직하게는, In the above synthesis method, step (d) is preferably,
시스-2-메틸옥타덱-7-엔을 mCPBA와 반응시켜 시스-7,8-에폭시-2-메틸옥타데칸을 합성한다. Cis-2-methyloctadec-7-ene is reacted with mCPBA to synthesize cis-7,8-epoxy-2-methyloctadecane.
상기 단계 (d)는, 더욱 바람직하게는, The step (d) is more preferably,
시스-2-메틸옥타덱-7-엔과 메틸렌 클로라이드를 8~15분 동안 교반하면서 반응시키는 단계;Reacting cis-2-methyloctadec-7-ene and methylene chloride with stirring for 8 to 15 minutes;
이어서 0℃에서 mCPBA와 메틸렌 클로라이드를 가하고 실온에서 4~8시간 동안 교반하면서 반응시키는 단계;Next, adding mCPBA and methylene chloride at 0°C and reacting with stirring at room temperature for 4 to 8 hours;
이어서 NaHCO3(탄산수소나트륨) 수용액을 가하여 10~20분 동안 교반하는 단계;Next, adding NaHCO 3 (sodium bicarbonate) aqueous solution and stirring for 10 to 20 minutes;
이어서 NaHCO3 수용액이 부가된 상태로 추출하는 단계;Next, extraction with NaHCO 3 aqueous solution added;
상기 추출된 유기층을 세척 및 농축하는 단계; 및Washing and concentrating the extracted organic layer; and
상기 농축으로 얻어진 농축물을 정제하는 단계를 포함한다. and purifying the concentrate obtained by the concentration.
본 발명은 출발물질로 3-부틴올을 사용하고, 종래 사용되고 있는 고가의 Pd 대신 저가의 값싼 Ni(OAc)2 를 촉매로 사용한 촉매환원 반응과 그리냐르 반응으로 매미나방의 성페로몬인 시스-7,8-에폭시-2-메틸옥타데칸을 대량으로 합성한다. The present invention uses 3-butynol as a starting material and cis-7, the sex pheromone of the gypsy moth, through a catalytic reduction reaction and Grignard reaction using inexpensive Ni(OAc) 2 as a catalyst instead of the expensive Pd used conventionally. , 8-Epoxy-2-methyloctadecane is synthesized in large quantities.
본 발명에 따라 합성된 7,8-에폭시-2-메틸옥타데칸은 매미나방의 성페로몬을 이용하는 트랩에 유인제로 사용하여 야외에서 매미나방의 발생여부를 보다 쉽게 예찰할 수 있고, 이를 바탕으로 농가 등에 대량으로 포획트랩을 보급함으로써 화학농약을 사용하지 않는 환경친화적인 방법으로 해충인 매미나방을 방제할 수 있다.7,8-Epoxy-2-methyloctadecane synthesized according to the present invention can be used as an attractant in traps using the sex pheromone of the gypsy moth to more easily monitor the occurrence of gypsy moths outdoors, and based on this, farmers can more easily monitor the occurrence of gypsy moths in the field. By distributing traps in large quantities, it is possible to control the gypsy moth, a pest, in an environmentally friendly way that does not use chemical pesticides.
본 발명에서 매미나방의 성페로몬인 시스-7,8-에폭시-2-메틸옥타데칸을 합성방법은 아래 (a)에서 (d)단계를 포함한다. In the present invention, the method for synthesizing cis-7,8-epoxy-2-methyloctadecane, a sex pheromone of gypsy moth, includes steps (a) to (d) below.
(a) 3-부틴올의 -OH기에 보호기를 도입하고 1-할로데칸과 반응시킨 후 보호기를 제거하여 테트라덱-3-인-1-올을 합성하는 단계;(a) synthesizing tetradec-3-yn-1-ol by introducing a protecting group into the -OH group of 3-butynol, reacting it with 1-halodecane, and then removing the protecting group;
(b) 테트라덱-3-인-1-올을 Ni(oAc)2 촉매 하에 부분 수소화 반응시켜 시스-테트라덱-3-엔-1-올을 합성하는 단계;(b) synthesizing cis-tetradec-3-en-1-ol by partial hydrogenation of tetradec-3-yn-1-ol under a Ni(oAc) 2 catalyst;
(c) 시스-테트라덱-3-엔-1-올의 -OH기를 토실레이트화 한 후 이소펜틸마그네슘 브로마이드로 그리냐르 반응시켜 시스-2-메틸옥타덱-7-엔을 합성하는 단계; 및(c) synthesizing cis-2-methyloctadec-7-ene by tosylating the -OH group of cis-tetradec-3-en-1-ol and then subjecting it to Grignard reaction with isopentylmagnesium bromide; and
(d) 시스-2-메틸옥타덱-7-엔을 에폭시화 반응시켜 시스-7,8-에폭시-2-메틸옥타데칸을 합성하는 단계.(d) Synthesizing cis-7,8-epoxy-2-methyloctadecane by epoxidizing cis-2-methyloctadec-7-ene.
이하 각 단계별로 본 발명을 상세하게 설명한다.Hereinafter, the present invention will be described in detail for each step.
1. 단계 (a): 3-부틴올로부터 테트라덱-3-인-1-올의 합성1. Step (a): Synthesis of tetradec-3-yn-1-ol from 3-butynol
3-부틴올의 -OH기에 보호기를 도입하고 1-할로데칸과 반응시킨 후 보호기를 제거하여 테트라덱-3-인-1-올을 합성한다. 상기 1-할로데칸은 바람직하게는 1-브로모데칸을 사용할 수 있다. 상기 보호기로는, 예를 들어, -OTHP기를 도입할 수 있다. 본 단계의 바람직한 일 실시예는 아래 반응식 1과 같다. Tetradec-3-yn-1-ol is synthesized by introducing a protecting group to the -OH group of 3-butynol, reacting it with 1-halodecane, and then removing the protecting group. The 1-halodecane is preferably 1-bromodecane. As the protecting group, for example, -OTHP group can be introduced. A preferred example of this step is shown in Scheme 1 below.
[반응식 1][Scheme 1]
바람직한 실시예에 따른 구체적인 합성 과정은 아래와 같다.The specific synthesis process according to the preferred embodiment is as follows.
(1) 보호기 도입(1) Introduction of protecting group
먼저 보호기를 도입하기 위해, 출발물질인 3-부틴올(3-butynol)에 3-부틴올, 피리디늄 p-톨루엔술포네이트(Pyridinium p-toluenesulfonate) 및 3,4-디하이드로-2H-피란(3,4-Dihydro-2H-pyran)을 가하고 반응시켜 2-(부트-3-인-1-일옥시)테트라하이드로-2H-피란을 합성한다.First, in order to introduce a protecting group, 3-butynol, pyridinium p-toluenesulfonate, and 3,4-dihydro-2H-pyran ( 3,4-Dihydro-2H-pyran) is added and reacted to synthesize 2-(but-3-yn-1-yloxy)tetrahydro-2H-pyran.
3-부틴올은 용매인 메틸렌 클로라이드(methylene chloride)에 용해시켜 사용한다. 3-부틴올에 용매인 메틸렌 클로라이드를 혼합하고 8~15분 동안 교반하면서 메틸렌 클로라이드에 3-부틴올을 용해시키는 것이 바람직하다. 10분 동안 교반하는 것이 보다 바람직하다.3-Butynol is used by dissolving it in methylene chloride, a solvent. It is preferable to mix 3-butynol with methylene chloride as a solvent and stir for 8 to 15 minutes to dissolve 3-butynol in methylene chloride. It is more preferable to stir for 10 minutes.
3-부틴올이 메틸렌 클로라이드에 완전히 용해되면, 온도를 0℃로 유지하면서 피리디늄 p-톨루엔술포네이트와 3,4-디하이드로-2H-피란을 혼합하고 실온에서 3~6시간 동안 교반하면서 반응시킨다. 4시간 동안 교반하는 것이 보다 바람직하다.When 3-butynol is completely dissolved in methylene chloride, mix pyridinium p-toluenesulfonate and 3,4-dihydro-2H-pyran while maintaining the temperature at 0°C and react while stirring at room temperature for 3 to 6 hours. I order it. It is more preferable to stir for 4 hours.
이때 TLC(Thin-Layer Chromatography)로 반응의 진행정도를 확인하는 것이 바람직하다.At this time, it is advisable to check the progress of the reaction using TLC (Thin-Layer Chromatography).
반응이 종료되면 감압하여 용매인 메틸렌 클로라이드를 제거한다. 용매를 제거한 후 추출용매로 추출하고, 추출된 유기층을 세척 및 농축하고, 농축된 잔여물을 정제하여 2-(부트-3-인-1-일옥시)테트라하이드로-2H-피란을 얻는다. When the reaction is completed, the pressure is reduced and the solvent, methylene chloride, is removed. After removing the solvent, extraction is performed with an extraction solvent, the extracted organic layer is washed and concentrated, and the concentrated residue is purified to obtain 2-(but-3-yn-1-yloxy)tetrahydro-2H-pyran.
이때 추출용매로는 EtoAc(Ethyl acetate)/H20/NaHCO3 /NaCl을 사용하는 것이 바람직하고, 농축된 잔여물은 실리카겔 칼럼(헥산/에테르:9/1)을 사용하여 정제하는 것이 바람직하다.At this time, it is preferable to use EtoAc (Ethyl acetate)/H 2 0/NaHCO 3 /NaCl as the extraction solvent, and the concentrated residue is preferably purified using a silica gel column (hexane/ether: 9/1). .
(2) 1-브로모데칸(1-bromodecane)과 반응(2) Reaction with 1-bromodecane
상기와 같이 보호기가 도입된 2-(부트-3-인-1-일옥시)테트라하이드로-2H-피란과, THF(Tetrahydrofuran), 헥사메틸포스포아미드(Hexamethylphosphoramide), n-부틸리튬(n-butyllithium) 및 1-브로모데칸(1-bromodecane)을 반응시켜 2-(테트라덱-3-인-1-일옥시)테트라하이드로-2H-피란을 합성한다. 2-(but-3-yn-1-yloxy)tetrahydro-2H-pyran, THF (Tetrahydrofuran), hexamethylphosphoramide, n-butyllithium (n- 2-(tetradec-3-yn-1-yloxy)tetrahydro-2H-pyran is synthesized by reacting butyllithium) and 1-bromodecane.
먼저, 2-(부트-3-인-1-일옥시)테트라하이드로-2H-피란, THF 및 헥사메틸포스포아미드를 혼합하여 반응시키고, 여기에 n-부틸리튬을 혼합하여 반응시키고, 1-브로모데칸을 혼합하여 반응시켜 2-(테트라덱-3-인-1-일옥시)테트라하이드로-2H-피란을 얻는다.First, 2-(but-3-yn-1-yloxy)tetrahydro-2H-pyran, THF, and hexamethylphosphoramide were mixed and reacted, and n-butyllithium was mixed and reacted, 1- Bromodecane is mixed and reacted to obtain 2-(tetradec-3-yn-1-yloxy)tetrahydro-2H-pyran.
2-(부트-3-인-1-일옥시)테트라하이드로-2H-피란, THF 및 헥사메틸포스포아미드는 2-(부트-3-인-1-일옥시)테트라하이드로-2H-피란과 THF를 먼저 혼합하고 헥사메틸포스포아미드를 가하여 8~15분 동안 교반하면서 반응시킨다. 약 10분 동안 교반하는 것이 보다 바람직하다.2-(but-3-yn-1-yloxy)tetrahydro-2H-pyran, THF and hexamethylphosphoramide are 2-(but-3-yn-1-yloxy)tetrahydro-2H-pyran THF is mixed first, then hexamethylphosphoramide is added and reacted with stirring for 8 to 15 minutes. It is more preferred to stir for about 10 minutes.
반응시킨 2-(부트-3-인-1-일옥시)테트라하이드로-2H-피란, THF 및 헥사메틸포스포아미드를 -40℃의 온도로 유지하면서 n-부틸리튬을 혼합하고 8~15분 동안 교반하면서 반응시킨다. 반응시킨 후 온도를 0℃로 올려 유지시키면서 25~40분 동안 교반한 후 다시 -40℃로 냉각시킨다. 30분 동안 교반하는 것이 보다 바람직하다.The reacted 2-(but-3-yn-1-yloxy)tetrahydro-2H-pyran, THF and hexamethylphosphoramide were mixed with n-butyllithium while maintaining the temperature at -40°C and incubated for 8 to 15 minutes. React while stirring. After reaction, the temperature is raised to 0°C and stirred for 25 to 40 minutes, then cooled to -40°C. It is more preferable to stir for 30 minutes.
-40℃로 다시 냉각시킨 후 1-브로모데칸을 혼합하고 실온에서 13~18시간 동안 교반하면서 반응시킨다. 15시간 동안 교반하는 것이 보다 바람직하다.After cooling again to -40°C, 1-bromodecane is mixed and reacted with stirring for 13 to 18 hours at room temperature. It is more preferable to stir for 15 hours.
이때 TLC로 반응의 진행정도를 확인하는 것이 바람직하다.At this time, it is advisable to check the progress of the reaction using TLC.
반응이 종료되면 적당량의 물(H2O)을 천천히 혼합한다. 물을 혼합한 후 추출용매로 추출하고, 추출된 유기층을 세척 및 농축하고, 농축된 잔여물을 정제하여 2-(테트라덱-3-인-1-일옥시)테트라하이드로-2H-피란을 얻는다. When the reaction is completed, an appropriate amount of water (H 2 O) is slowly mixed. After mixing with water, extraction is performed with an extraction solvent, the extracted organic layer is washed and concentrated, and the concentrated residue is purified to obtain 2-(tetradec-3-yn-1-yloxy)tetrahydro-2H-pyran. .
이때 추출용매로는 EtoAc/H20/NaCl을 사용하고, 농축된 잔여물은 실리카겔 칼럼(헥산/에테르 : 20/1)를 사용하여 정제하는 것이 바람직하다.At this time, it is preferable to use EtoAc/H 2 O/NaCl as the extraction solvent, and purify the concentrated residue using a silica gel column (hexane/ether: 20/1).
(3) 보호기 제거(3) Removal of protecting group
위에서 얻은 2-(테트라덱-3-인-1-일옥시)테트라하이드로-2H-피란과 p-톨루엔술폰산(p-Toluenesulfonic acid)을 반응시켜 테트라덱-3-인-1-올을 합성한다.Tetradec-3-yn-1-ol is synthesized by reacting 2-(tetradec-3-yn-1-yloxy)tetrahydro-2H-pyran obtained above with p-Toluenesulfonic acid. .
2-(테트라덱-3-인-1-일옥시)테트라하이드로-2H-피란은 용매인 메탄올에 용해시켜 사용한다. 2-(테트라덱-3-인-1-일옥시)테트라하이드로-2H-피란에 용매인 메탄올을 혼합하고 8~15분 동안 교반하면서 메탄올에 2-(테트라덱-3-인-1-일옥시)테트라하이드로-2H-피란을 용해시키는 것이 바람직하다. 10분 동안 교반하는 것이 보다 바람직하다.2-(Tetradec-3-yn-1-yloxy)tetrahydro-2H-pyran is used by dissolving it in methanol, a solvent. Mix 2-(tetradec-3-yn-1-yloxy)tetrahydro-2H-pyran with methanol as a solvent and stir for 8 to 15 minutes to dissolve 2-(tetradec-3-yn-1-yloxy) in methanol. si) It is desirable to dissolve tetrahydro-2H-pyran. It is more preferable to stir for 10 minutes.
2-(테트라덱-3-인-1-일옥시)테트라하이드로-2H-피란이 메탄올에 완전히 용해되면, p-톨루엔술폰산을 혼합하고 실온에서 3~6시간 동안 교반하면서 반응시킨다. 4시간 동안 교반하는 것이 보다 바람직하다.When 2-(tetradec-3-yn-1-yloxy)tetrahydro-2H-pyran is completely dissolved in methanol, p-toluenesulfonic acid is mixed and reacted with stirring at room temperature for 3 to 6 hours. It is more preferable to stir for 4 hours.
이때 TLC로 반응의 진행정도를 확인하는 것이 바람직하다.At this time, it is advisable to check the progress of the reaction using TLC.
반응이 종료되면 감압하여 용매인 메탄올을 제거한다. 용매를 제거한 후 추출용매로 추출하고, 추출된 유기층을 세척 및 농축하고, 농축된 잔여물을 정제하여 테트라덱-3-인-1-올을 얻는다.When the reaction is completed, the pressure is reduced and the solvent, methanol, is removed. After removing the solvent, extraction is performed with an extraction solvent, the extracted organic layer is washed and concentrated, and the concentrated residue is purified to obtain tetradec-3-yn-1-ol.
감압하여 용매를 제거할 때 NaHCO3를 사용하는 것이 바람직하다. 추출용매로는 에테르/H20/NaCl을 사용하고, 농축된 잔여물은 실리카겔 칼럼(헥산/EtOAC : 9/1)을 사용하여 정제하는 것이 바람직하다.It is preferable to use NaHCO 3 when removing the solvent by reducing the pressure. It is preferable to use ether/H 2 O/NaCl as an extraction solvent, and purify the concentrated residue using a silica gel column (hexane/EtOAC: 9/1).
2. 단계 (b): 시스-테트라덱-3-엔-1-올(cis-tetradec-3-en-1-ol)의 합성2. Step (b): Synthesis of cis-tetradec-3-en-1-ol
위에서 얻은 테트라덱-3-인-1-올을 Ni(oAc)2 촉매 하에 부분 수소화 반응시켜 시스-테트라덱-3-엔-1-올을 합성한다. 본 단계의 바람직한 일 실시예는 아래 반응식 2와 같다. Tetradec-3-yn-1-ol obtained above is subjected to partial hydrogenation under a Ni(oAc) 2 catalyst to synthesize cis-tetradec-3-en-1-ol. A preferred example of this step is shown in Scheme 2 below.
[반응식 2][Scheme 2]
본 단계는 바람직하게는, This step is preferably:
Ni(oAc)2와 NaBH4를 각각 용매 에탄올에 용해시키는 단계;Dissolving Ni(oAc) 2 and NaBH 4 in the solvent ethanol, respectively;
메탄올에 용해된 Ni(oAc)2와 NaBH4를 교반하면서 혼합하는 단계;Mixing Ni(oAc) 2 and NaBH 4 dissolved in methanol with stirring;
상기 혼합물에 에틸렌디아민과 테트라덱-3-인-1-올을 혼합하고 수소를 주입하여 실온에서 4~8시간 동안 교반하면서 반응시키는 단계;Mixing ethylenediamine and tetradec-3-yn-1-ol in the mixture, injecting hydrogen and reacting with stirring at room temperature for 4 to 8 hours;
상기 용매를 제거하는 단계;removing the solvent;
추출용매로 추출하는 단계;Extracting with an extraction solvent;
추출된 유기층을 세척 및 농축하는 단계; 및 Washing and concentrating the extracted organic layer; and
농축된 잔여물을 정제하는 단계를 포함한다. and purifying the concentrated residue.
바람직한 일 실시예를 구체적으로 설명한다.A preferred embodiment will be described in detail.
먼저, Ni(oAc)2와 NaBH4를 혼합하고, 이 혼합물에 에틸렌디아민(Ethylenediamine)과 테트라덱-3-인-1-올을 혼합하고 수소를 주입하여 반응시킨다. First, Ni(oAc) 2 and NaBH 4 are mixed, and ethylenediamine and tetradec-3-yn-1-ol are mixed into this mixture and hydrogen is injected to react.
Ni(oAc)2와 NaBH4는 각각 용매인 에탄올에 용해시켜 사용한다. Ni(oAc)2와 NaBH4를 혼합하고 4~8분 동안 교반한다. 5분 동안 교반하는 것이 보다 바람직하다.Ni(oAc) 2 and NaBH 4 are each used by dissolving in ethanol, a solvent. Mix Ni(oAc) 2 and NaBH 4 and stir for 4 to 8 minutes. It is more preferable to stir for 5 minutes.
이 혼합물에 에틸렌디아민과 테트라덱-3-인-1-올을 혼합하고 수소를 주입하여 교반하면서 반응시킨다. 실온에서 4~8시간 동안 교반하는 것이 바람직하며, 5시간 동안 교반하는 것이 보다 바람직하다.Ethylenediamine and tetradec-3-yn-1-ol are mixed in this mixture, hydrogen is injected, and the mixture is stirred to react. It is preferable to stir at room temperature for 4 to 8 hours, and more preferably for 5 hours.
이때 TLC로 반응의 진행정도를 확인하는 것이 바람직하다.At this time, it is advisable to check the progress of the reaction using TLC.
반응이 종료되면 여과하여 용매를 제거한다. 용매를 제거한 후 추출용매로 추출하고, 추출된 유기층을 세척 및 농축하고, 농축된 잔여물을 정제하여 시스-테트라덱-3-엔-1-올을 얻는다. When the reaction is completed, the solvent is removed by filtration. After removing the solvent, extraction is performed with an extraction solvent, the extracted organic layer is washed and concentrated, and the concentrated residue is purified to obtain cis-tetradec-3-en-1-ol.
여과시에는 에테르를 사용하고, 추출용매로는 에테르/H20/NaCl을 사용하고, 농축된 잔여물은 실리카겔 칼럼(헥산/에테르 : 4/1)을 사용하여 정제하는 것이 바람직하다.It is preferable to use ether during filtration, ether/H 2 O/NaCl as an extraction solvent, and purify the concentrated residue using a silica gel column (hexane/ether: 4/1).
3. 단계 (c): 시스-2-메틸옥타덱-7-엔 (cis-2-methyloctadec-7-ene)의 합성3. Step (c): Synthesis of cis-2-methyloctadec-7-ene
위에서 얻은 시스-테트라덱-3-엔-1-올의 -OH기를 토실레이트화 한 후 이소펜틸마그네슘 브로마이드로 그리냐르 반응시켜 시스-2-메틸옥타덱-7-엔을 합성한다. 본 단계의 바람직한 일 실시예는 아래 반응식 3과 같다. The -OH group of cis-tetradec-3-en-1-ol obtained above is tosylated and subjected to Grignard reaction with isopentylmagnesium bromide to synthesize cis-2-methyloctadec-7-ene. A preferred example of this step is shown in Scheme 3 below.
[반응식 3][Scheme 3]
본 단계는 바람직하게는, This step is preferably:
시스-테트라덱-3-엔-1-올을 p-톨루엔설포닐 클로라이드와 반응시켜 시스-테트라덱-3-엔-1-일 4-메틸벤젠술포네이트를 합성한 후, 이소펜틸마그네슘 브로마이드로 그리냐르 반응시켜 시스-2-메틸옥타덱-7-엔을 합성한다. Cis-tetradec-3-en-1-ol was reacted with p-toluenesulfonyl chloride to synthesize cis-tetradec-3-en-1-yl 4-methylbenzenesulfonate, and then reacted with isopentylmagnesium bromide. Cis-2-methyloctadec-7-ene is synthesized through Grignard reaction.
바람직한 일 실시예를 구체적으로 설명한다.A preferred embodiment will be described in detail.
시스-테트라덱-3-엔-1-올, 피리딘(Pyridine) 및 p-톨루엔설포니 클로라이드(p-toluensulfony chloride)를 반응시켜 시스-테트라덱-3-엔-1-일 4-메틸벤젠술포네이트를 합성한다.Cis-tetradec-3-en-1-ol, pyridine, and p-toluensulfony chloride are reacted to produce cis-tetradec-3-en-1-yl 4-methylbenzenesulfo. Synthesize Nate.
시스-테트라덱-3-엔-1-올과 피리딘을 먼저 혼합한 후 p-톨루엔설포니 클로라이드를 가하여 교반하면서 반응시킨다. 실온에서 4~7시간 동안 교반하는 것이 바람직하며, 5시간 동안 교반하는 것이 보다 바람직하다.Cis-tetradec-3-en-1-ol and pyridine are first mixed, then p-toluenesulfony chloride is added and reacted with stirring. It is preferable to stir at room temperature for 4 to 7 hours, and more preferably for 5 hours.
이때 TLC로 반응의 진행정도를 확인하는 것이 바람직하다.At this time, it is advisable to check the progress of the reaction using TLC.
반응이 종료되면 ether로 여과(filter)시킨 후 용매를 제거하고, 추출용매로 추출한 후, 추출된 유기층을 세척 및 농축하고, 농축된 잔여물을 정제하여 시스-테트라덱-3-엔-1-일 4-메틸벤젠술포네이트를 얻는다. 이때 추출용매로는 에테르/H2O/Na2SO4를 사용하는 것이 바람직하고, 실리카겔 칼럼(헥산/EtOAC : 9/1)을 사용하여 정제하는 것이 바람직하다.When the reaction is completed, the solvent is removed after filtering with ether, extraction is performed with an extraction solvent, the extracted organic layer is washed and concentrated, and the concentrated residue is purified to produce cis-tetradec-3-en-1- 4-methylbenzenesulfonate is obtained. At this time, it is preferable to use ether/H 2 O/Na 2 SO 4 as the extraction solvent, and it is preferable to purify using a silica gel column (hexane/EtOAC: 9/1).
이렇게 얻어진 시스-테트라덱-3-엔-1-일 4-메틸벤젠술포네이트를 그리냐르 시약(Grignard Reagent)과 반응시켜 시스-2-메틸옥타덱-7-엔을 합성한다.Cis-tetradec-3-en-1-yl 4-methylbenzenesulfonate thus obtained is reacted with Grignard Reagent to synthesize cis-2-methyloctadec-7-ene.
그리냐르 시약은 Mg과 I2의 혼합물에 1-브로모-3-메틸부탄(1-bromo-3-methylbutane)과 THF의 혼합물을 서서히 가하면서 끓어서 변색될 때까지 가열 및 교반하여 합성한다.Grignard reagent is synthesized by slowly adding a mixture of 1-bromo-3-methylbutane and THF to a mixture of Mg and I 2 and heating and stirring until it boils and discolors.
합성한 그리냐르 시약을 시스-테트라덱-3-엔-1-일 4-메틸벤젠술포네이트 및 THF에 서서히 부가하여 교반하면서 반응시킨다. 이때 -10℃의 온도에서 반응시키는 것이 바람직하다. 8~15분 동안 교반하는 것이 바람직하고 10분 동안 교반하는 것이 보다 바람직하다.The synthesized Grignard reagent is slowly added to cis-tetradec-3-en-1-yl 4-methylbenzenesulfonate and THF and reacted with stirring. At this time, it is preferable to carry out the reaction at a temperature of -10°C. It is preferable to stir for 8 to 15 minutes, and more preferably for 10 minutes.
교반 후 0.1M Li2CuCl4를 부가하여 교반하면서 반응시킨다. 실온에서 2~5시간 동안 교반하는 것이 바람직하고, 3시간 동안 교반하는 것이 보다 바람직하다.After stirring, 0.1M Li 2 CuCl 4 was added and reacted with stirring. It is preferable to stir at room temperature for 2 to 5 hours, and more preferably for 3 hours.
이때 TLC로 반응의 진행정도를 확인하는 것이 바람직하다.At this time, it is advisable to check the progress of the reaction using TLC.
반응이 종료되면 NH4Cl(염화암모늄) 수용액을 푸른빛이 될 때까지 혼합하고, 추출용매로 추출하고, 추출된 유기층을 세척 및 농축하고, 농축된 잔여물을 정제하여 시스-2-메틸옥타덱-7-엔을 얻는다. When the reaction is completed, NH 4 Cl (ammonium chloride) aqueous solution is mixed until it turns blue, extracted with an extraction solvent, the extracted organic layer is washed and concentrated, and the concentrated residue is purified to produce cis-2-methylocta. Get Deck-7-N.
추출용매로는 에틸에테르/NH4Cl/NaCl을 사용하는 것이 바람직하고, 실리카겔 칼럼(헥산 100%)을 사용하여 정제하는 것이 바람직하다.It is preferable to use ethyl ether/NH 4 Cl/NaCl as an extraction solvent, and it is preferable to purify using a silica gel column (100% hexane).
4. 단계 (d): 시스-7,8-에폭시-2-메틸옥타데칸 (cis-7,8-epoxy-2-methyloctadecane; (±)-Disparlure)의 합성4. Step (d): Synthesis of cis-7,8-epoxy-2-methyloctadecane (±)-Disparlure)
위에서 얻은 시스-2-메틸옥타덱-7-엔을 에폭시화 반응시켜 시스-7,8-에폭시-2-메틸옥타데칸을 합성한다. 본 단계의 바람직한 일 실시예는 아래 반응식 4와 같다. Cis-2-methyloctadec-7-ene obtained above is subjected to an epoxidation reaction to synthesize cis-7,8-epoxy-2-methyloctadecane. A preferred example of this step is shown in Scheme 4 below.
[반응식 4][Scheme 4]
본 단계는 바람직하게는, This step is preferably:
시스-2-메틸옥타덱-7-엔을 mCPBA와 반응시켜 시스-7,8-에폭시-2-메틸옥타데칸을 합성한다. Cis-2-methyloctadec-7-ene is reacted with mCPBA to synthesize cis-7,8-epoxy-2-methyloctadecane.
본 단계는 더욱 바람직하게는,This step is more preferably:
시스-2-메틸옥타덱-7-엔과 메틸렌 클로라이드를 8~15분 동안 교반하면서 반응시키는 단계;Reacting cis-2-methyloctadec-7-ene and methylene chloride with stirring for 8 to 15 minutes;
이어서 0℃에서 mCPBA와 메틸렌 클로라이드를 가하고 실온에서 4~8시간 동안 교반하면서 반응시키는 단계;Next, adding mCPBA and methylene chloride at 0°C and reacting with stirring at room temperature for 4 to 8 hours;
이어서 NaHCO3(탄산수소나트륨) 수용액을 가하여 10~20분 동안 교반하는 단계;Next, adding NaHCO 3 (sodium bicarbonate) aqueous solution and stirring for 10 to 20 minutes;
이어서 NaHCO3 수용액이 부가된 상태로 추출하는 단계;Next, extraction with NaHCO 3 aqueous solution added;
상기 추출된 유기층을 세척 및 농축하는 단계; 및Washing and concentrating the extracted organic layer; and
상기 농축으로 얻어진 농축물을 정제하는 단계를 포함한다. and purifying the concentrate obtained by the concentration.
본 단계의 바람직한 일 실시예를 구체적으로 설명한다.A preferred embodiment of this step will be described in detail.
시스-2-메틸옥타덱-7-엔, 메틸렌 클로라이드 및 mCPBA(Meta-Chloroperoxybenzoic acid)를 반응시켜 시스-7,8-에폭시-2-메틸옥타데칸을 합성한다.Cis-2-methyloctadec-7-ene, methylene chloride, and mCPBA (Meta-Chloroperoxybenzoic acid) are reacted to synthesize cis-7,8-epoxy-2-methyloctadecane.
먼저, 시스-2-메틸옥타덱-7-엔과 메틸렌 클로라이드를 교반하면서 반응시킨다. 8~15분 동안 교반하는 것이 바람직하며, 10분 동안 교반하는 것이 보다 바람직하다.First, cis-2-methyloctadec-7-ene and methylene chloride are reacted with stirring. It is preferable to stir for 8 to 15 minutes, and more preferably for 10 minutes.
반응 후 0℃로 온도를 설정하여 mCPBA와 메틸렌 클로라이드를 가하여 실온에서 교반하면서 반응시킨다. 4~8시간 동안 교반하는 것이 바람직하고, 6시간 동안 교반하는 것이 보다 바람직하다.After reaction, set the temperature to 0°C, add mCPBA and methylene chloride, and react with stirring at room temperature. It is preferable to stir for 4 to 8 hours, and more preferably for 6 hours.
이때 TLC로 반응의 진행정도를 확인하는 것이 바람직하다.At this time, it is advisable to check the progress of the reaction using TLC.
반응이 종료되면 NaHCO3(탄산수소나트륨) 수용액을 가하여 10~20분 동안 교반하고, NaHCO3 수용액이 부가된 상태로 추출하고, 추출된 유기층을 세척 및 농축하고, 농축된 잔여물을 정제하여 시스-7,8-에폭시-2-메틸옥타데칸을 얻는다. When the reaction is completed, NaHCO 3 (sodium bicarbonate) aqueous solution is added and stirred for 10 to 20 minutes, extracted with the NaHCO 3 aqueous solution added, the extracted organic layer is washed and concentrated, and the concentrated residue is purified and purified. -7,8-epoxy-2-methyloctadecane is obtained.
실리카겔 칼럼(헥산/EtOAC : 20/1)을 사용하여 정제하는 것이 바람직하다.It is preferable to purify using a silica gel column (hexane/EtOAC: 20/1).
이하 실시예를 통하여 본 발명을 보다 상세하게 설명한다. 이들 실시예는 본 발명을 예시하는 것으로서 본 발명의 범위가 이에 한정되는 것은 아니다.The present invention will be described in more detail through examples below. These examples illustrate the present invention and the scope of the present invention is not limited thereto.
[실시예][Example]
시약, 장치 및 기기Reagents, Devices and Instruments
핵자기 공명 스펙트럼은 Avance Digital 500 MHz Spectrometer(Bruker, Ettlingen, Germany)를 이용하였다. 관 크로마토그래피는 실리카겔(Silica gel) 60(Merck KGaA, Darmstadt, Germany)을 사용하였다. 시약은 Sigma-Aldrich(Merck KGaA, Darmstadt, Germany)와 Sejin-Ci(Tokyo chemical industry, Tokyo, Japan)에서 구입하여 정제없이 사용하였으며, 용매는 정제하지 않고 사용하거나 증류 정제하여 사용하였다. 합성된 페로몬 성분의 가스크로마토그래피 분석은 YL 6500 GC(Youngin Chromass, Gyeonggi-do, Korea)와 TG-5Ms(30m×0.25mm I.D., 0.25㎛) (Thermo scientific, United States of America)을 이용하여 오븐온도 125℃, 흐름 속도 1.0㎖/min, 주입시료량 1 ㎕로 분석하였다.Nuclear magnetic resonance spectra were performed using an Avance Digital 500 MHz Spectrometer (Bruker, Ettlingen, Germany). For tube chromatography, silica gel 60 (Merck KGaA, Darmstadt, Germany) was used. Reagents were purchased from Sigma-Aldrich (Merck KGaA, Darmstadt, Germany) and Sejin-Ci (Tokyo chemical industry, Tokyo, Japan) and used without purification, and solvents were used without purification or after purification by distillation. Gas chromatographic analysis of the synthesized pheromone component was performed in an oven using YL 6500 GC (Youngin Chromass, Gyeonggi-do, Korea) and TG-5Ms (30m × 0.25mm I.D., 0.25㎛) (Thermo scientific, United States of America). The analysis was performed at a temperature of 125°C, a flow rate of 1.0 ㎖/min, and an injection sample volume of 1 ㎕.
<실시예 1><Example 1>
다음과 같이 시스-7,8-에폭시-2-메틸옥타데칸{(±)-Disparlure)}을 합성하였다.Cis-7,8-epoxy-2-methyloctadecane {(±)-Disparlure)} was synthesized as follows.
[반응식 5][Scheme 5]
Reagent and conditions: Reagents and conditions:
(ⅰ) 1eq of 3-butynol, 0.0083eq of PPTs, 1.5eq of DHP, MC, rt, 4hr, 81% (i) 1eq of 3-butynol, 0.0083eq of PPTs, 1.5eq of DHP, MC, rt, 4hr, 81%
(ⅱ) 1.3eq of 1-bromodecane, 1.25eq of 1.6M BuLi, HMPA, THF, rt, 15hr, 61% (ii) 1.3eq of 1-bromodecane, 1.25eq of 1.6M BuLi, HMPA, THF, rt, 15hr, 61%
(ⅲ) 0.1eq of PTSA, MeOH, NaHCO3, rt, 2hr, 71.3% (iii) 0.1eq of PTSA, MeOH, NaHCO 3 , rt, 2hr, 71.3%
(ⅳ) 0.1667eq of NaBH4, 0.1667eq of Ni(oAc)2, 95%EtOH, 0.42eq of Ethylenediamine, rt, 5hr, 78%(iv) 0.1667eq of NaBH4, 0.1667eq of Ni(oAc)2, 95%EtOH, 0.42eq of Ethylenediamine, rt, 5hr, 78%
(ⅴ) 1.5eq of P-toluensulfony chloride, Pyridine, rt, 5hr, 87%(v) 1.5eq of P-toluensulfony chloride, Pyridine, rt, 5hr, 87%
(ⅵ) Grignard reagent - 5eq of 1-bromo-3-methylbutane, 7.5eq of Mg,, I2, THF, 0.01eq of 0.1M Li2CuCl4, THF, rt, 3hr, 48% (ⅵ) Grignard reagent - 5eq of 1-bromo-3-methylbutane, 7.5eq of Mg,, I 2, THF, 0.01eq of 0.1M Li 2 CuCl 4 , THF, rt, 3hr, 48%
(ⅶ) 1.22eq of MCPBA, MC, rt, 6hr, 38%(ⅶ) 1.22eq of MCPBA, MC, rt, 6hr, 38%
이하 (ⅰ) 내지 (ⅶ) 각각의 공정을 설명한다. Each process (i) to (vii) will be described below.
(ⅰ) 2-(부트-3-인-1-일옥시)테트라하이드로-2H-피란의 합성(i) Synthesis of 2-(but-3-yn-1-yloxy)tetrahydro-2H-pyran
장치한 플라스크에 3-부틴올(10.74g, 0.153mol)을 넣고 용매인 메틸렌 클로라이드(107.4㎖)를 부가하여 10분 동안 교반하였다. 플라스크의 온도를 0℃로 유지하면서 피리디늄 p-톨루엔술포네이트(0.32g, 0.001mol)와 3,4-디하이드로-2H-피란(20.85㎖, 0.191mol)를 부가하여 실온에서 4시간 동안 교반하면서 반응시켰다.3-Butynol (10.74 g, 0.153 mol) was added to the flask, methylene chloride (107.4 ml) as a solvent was added, and the mixture was stirred for 10 minutes. While maintaining the temperature of the flask at 0°C, pyridinium p-toluenesulfonate (0.32 g, 0.001 mol) and 3,4-dihydro-2H-pyran (20.85 ml, 0.191 mol) were added and stirred at room temperature for 4 hours. and reacted.
TLC로 반응의 진행정도를 확인하여 종료 후 용매를 감압하여 제거하고, EtoAc/H20/NaHCO3/NaCl로 추출하고, 추출된 유기층을 세척하고 농축하고, 농축된 잔여물을 실리카겔 칼럼(hexane/ether:4/1)으로 정제하여 2-(부트-3-인-1-일옥시)테트라하이드로-2H-피란(화합물 2)(19.14g, 81%)을 얻었다. The progress of the reaction was checked by TLC. After completion, the solvent was removed under reduced pressure, extracted with EtoAc/H 2 0/NaHCO 3 /NaCl, the extracted organic layer was washed and concentrated, and the concentrated residue was purified on a silica gel column (hexane). /ether:4/1) to obtain 2-(but-3-yn-1-yloxy)tetrahydro-2H-pyran (Compound 2) (19.14 g, 81%).
2-(부트-3-인-1-일옥시)테트라하이드로-2H-피란(화합물 2)의 NMR 분석결과는 다음과 같다:The NMR analysis results of 2-(but-3-yn-1-yloxy)tetrahydro-2H-pyran (Compound 2) are as follows:
1H NMR (CDCl3, 500MHz) δ 4.65 (dd, J=4.2, 3.0Hz, 1H), 3.93-3.80 (m, 2H), 3.62-3.48 (m, 2H), 2.50 (td, J=7.0, 2.6Hz, 2H), 1.98 (d, J=5.3Hz, 1H), 1.89-1.78 (m, 1H), 1.77-1.67(m, 1H), 1.66-1.47(m, 4H) ; 13C NMR (CDCl3, 126MHz) δ 98.79, 69.18, 65.53, 62.24, 30.55, 25.43, 19.96, 19.41 1H NMR (CDCl 3 , 500MHz) δ 4.65 (dd, J =4.2, 3.0Hz, 1H), 3.93-3.80 (m, 2H), 3.62-3.48 (m, 2H), 2.50 (td, J =7.0, 2.6Hz, 2H), 1.98 (d, J =5.3Hz, 1H), 1.89-1.78 (m, 1H), 1.77-1.67(m, 1H), 1.66-1.47(m, 4H) ; 13 C NMR (CDCl 3 , 126 MHz) δ 98.79, 69.18, 65.53, 62.24, 30.55, 25.43, 19.96, 19.41
(ⅱ) 2-(테트라덱-3-인-1-일옥시)테트라하이드로-2H-피란의 합성 (ii) Synthesis of 2-(tetradec-3-yn-1-yloxy)tetrahydro-2H-pyran
장치한 플라스크에 (부트-3-인-1-일옥시)테트라하이드로-2H-피란(화합물 2)(19.14g, 0.124mol)와 THF(478.52㎖)를 혼합하고 HMPA(28.54㎖)를 부가하여 10분 동안 교반하였다. 플라스크의 온도를 -40℃로 유지하면서 1.6M n-부틸리튬(97㎖, 0.155mol)을 혼합하고 10분 동안 교반하였다. 교반시킨 플라스크의 온도를 0℃로 올려 유지하면서 30분 동안 교반하였다. 교반 후 다시 -40℃로 냉각시키고 1-브로모데칸(35.68g, 0.161mol)을 부가하여 실온에서 15시간 동안 교반하면서 반응시켰다. (But-3-yn-1-yloxy)tetrahydro-2H-pyran (Compound 2) (19.14 g, 0.124 mol) and THF (478.52 ml) were mixed in the flask, and HMPA (28.54 ml) was added. Stirred for 10 minutes. While maintaining the temperature of the flask at -40°C, 1.6M n-butyllithium (97 mL, 0.155 mol) was mixed and stirred for 10 minutes. The temperature of the stirred flask was maintained at 0°C and stirred for 30 minutes. After stirring, the mixture was cooled again to -40°C, 1-bromodecane (35.68 g, 0.161 mol) was added, and the reaction was stirred at room temperature for 15 hours.
TLC로 반응의 진행정도를 확인하여 종료하였다. 반응이 종료된 후 적당량의 H2O를 천천히 부가하였다. H2O를 부가한 후 EtoAc/H2O/H2O/NaCl로 추출하고, 추출된 유기층을 세척하고 농축하고, 농축된 잔여물을 실리카겔 칼럼(hexane/ether:20/1)으로 정제하여 2-(테트라덱-3-인-1-일옥시)테트라하이드로-2H-피란(화합물 3)(18.52g, 61%)을 얻었다. The progress of the reaction was confirmed by TLC and the reaction was terminated. After the reaction was completed, an appropriate amount of H 2 O was slowly added. After adding H 2 O, extraction was performed with EtoAc/H 2 O/H 2 O/NaCl, the extracted organic layer was washed and concentrated, and the concentrated residue was purified using a silica gel column (hexane/ether: 20/1). 2-(Tetradec-3-yn-1-yloxy)tetrahydro-2H-pyran (Compound 3) (18.52 g, 61%) was obtained.
2-(테트라덱-3-인-1-일옥시)테트라하이드로-2H-피란(화합물 3)의 NMR 분석결과는 다음과 같다:The NMR analysis results of 2-(tetradec-3-yn-1-yloxy)tetrahydro-2H-pyran (Compound 3) are as follows:
1H NMR (CDCl3, 500MHz) 4.65 (dd, J=4.2, 3.0Hz, 1H), 3.89 (ddd, J=11.2 8.2, 3.1Hz, 1H), 3.79 (dt, J=9.6, 7.2Hz, 1H), 3.57-3.47 (m, 2H), 2.46 (tt, J=7.3, 2.4Hz, 2H), 2.13 (tt, J= 7.1, 2.4Hz, 2H), 1.83 (dtt, J=13.2, 5.6, 2.6Hz, 1H), 1.76-1.67(m, 1H), 1.64-1.58 (m, 2H), 1.58-1.54 (m, 1H), 1.54-1.49 (m, 2H), 1.49-1.42 (m, 2H), 1.37 (dd, J=10.7, 5.3 Hz, 1H), 1.35-1.24 (m, 13H), 0.88(t, J=7.0Hz, 3H) ; 13C NMR (CDCl3, 126MHz) δ 98.72, 81.41, 76.72, 66.27, 62.17, 31.92, 30.61, 29.59 (d, J=5.9Hz), 29.27 (d, J=17.7Hz), 28.95 (d, J=19.3Hz), 25.48, 22.70, 20.26, 19.45, 18.77, 14.12 1H NMR (CDCl 3 , 500MHz) 4.65 (dd, J =4.2, 3.0Hz, 1H), 3.89 (ddd, J =11.2 8.2, 3.1Hz, 1H), 3.79 (dt, J =9.6, 7.2Hz, 1H) ), 3.57-3.47 (m, 2H), 2.46 (tt, J =7.3, 2.4Hz, 2H), 2.13 (tt, J = 7.1, 2.4Hz, 2H), 1.83 (dtt, J =13.2, 5.6, 2.6 Hz, 1H), 1.76-1.67(m, 1H), 1.64-1.58 (m, 2H), 1.58-1.54 (m, 1H), 1.54-1.49 (m, 2H), 1.49-1.42 (m, 2H), 1.37 (dd, J =10.7, 5.3 Hz, 1H), 1.35-1.24 (m, 13H), 0.88(t, J =7.0Hz, 3H) ; 13 C NMR (CDCl 3 , 126MHz) δ 98.72, 81.41, 76.72, 66.27, 62.17, 31.92, 30.61, 29.59 (d, J =5.9Hz), 29.27 (d, J =17.7Hz), 28.95 (d, J = 19.3Hz), 25.48, 22.70, 20.26, 19.45, 18.77, 14.12
(ⅲ) 테트라덱-3-인-1-올의 합성(iii) Synthesis of tetradec-3-yn-1-ol
장치한 플라스크에 2-(테트라덱-3-인-1-일옥시)테트라하이드로-2H-피란(화합물 3)(18.52g, 0.062mol)과 용매인 메탄올(277.5㎖)을 혼합하고 실온에서 10분 동안 교반한 후 p-톨루엔술폰산(1.44g, 0.007mol)을 혼합하고 실온에서 2시간 동안 교반하였다.2-(Tetradec-3-yn-1-yloxy)tetrahydro-2H-pyran (Compound 3) (18.52 g, 0.062 mol) and methanol (277.5 ml) as a solvent were mixed in the equipped flask and incubated for 10 minutes at room temperature. After stirring for several minutes, p-toluenesulfonic acid (1.44 g, 0.007 mol) was mixed and stirred at room temperature for 2 hours.
TLC로 반응의 진행정도를 확인하여 종료 후 NaHCO3(16.66g)를 혼합하고 용매를 감압하여 제거하였다. 에테르/H2O/NaCl로 추출하고, 추출된 유기층을 세척하고 농축하고, 농축된 잔여물을 실리카겔 칼럼(hexane/EtOAC:9/1)으로 정제하여 테트라덱-3-인-1-올(화합물 4)(11.36g, 71.3%)을 얻었다. The progress of the reaction was confirmed by TLC. After completion, NaHCO 3 (16.66 g) was mixed and the solvent was removed under reduced pressure. Extracted with ether/H 2 O/NaCl, washed and concentrated the extracted organic layer, and purified the concentrated residue with a silica gel column (hexane/EtOAC: 9/1) to produce tetradec-3-yn-1-ol ( Compound 4) (11.36 g, 71.3%) was obtained.
테트라덱-3-인-1-올(화합물 4)의 NMR 분석결과는 다음과 같다:The NMR analysis results of tetradec-3-yn-1-ol (compound 4) are as follows:
1H NMR (CDCl3, 500MHz) δ 3.68 (t, J=6.2, 2H), 2.43 (tt, J=6.2, 2.4 Hz, 2H), 2.16 (tt, J=7.2, 2.4Hz, 2H), 1.53-1.44 (m, 2H), 1.41-1.33(m, 2H), 1.33-1.23(m, 13H), 0.91-0.85 (m, 3H) ; 13C NMR (CDCl3, 126MHz) δ 82.84, 76.25, 61.40, 31.92, 29.69-29.25(m), 29.25-28.83(m), 23.22, 22.70, 18.75, 14.12 1H NMR (CDCl 3 , 500MHz) δ 3.68 (t, J =6.2, 2H), 2.43 (tt, J =6.2, 2.4 Hz, 2H), 2.16 (tt, J =7.2, 2.4Hz, 2H), 1.53 -1.44 (m, 2H), 1.41-1.33(m, 2H), 1.33-1.23(m, 13H), 0.91-0.85 (m, 3H) ; 13 C NMR (CDCl 3 , 126MHz) δ 82.84, 76.25, 61.40, 31.92, 29.69-29.25(m), 29.25-28.83(m), 23.22, 22.70, 18.75, 14.12
(ⅳ) 시스-테트라덱-3-엔-1-올의 합성(iv) Synthesis of cis-tetradec-3-en-1-ol
플라스크에 Ni(oAc)2 (0.98g, 0.004mol)에 에탄올(50.4㎖)을 부가하여 용해시키고 다른 플라스크에 NaBH4(0.15g, 0.004mol)에 에탄올(5.04㎖)을 부가하여 용해시킨 후 이들을 혼합하여 2-넥 플라스크(2-neck flask)에 장치하고 5분 정도 교반하였다. 혼합된 2-넥 플라스크에 에틸렌디아민(0.67㎖, 0.011mol)과 테트라덱-3-인-1-올(5.04g, 0.024mol)을 부가한 후 수소(H2)를 주입하여 실온에서 5시간 동안 교반하면서 반응시켰다.Ethanol (50.4 ml) was added to dissolve Ni(oAc) 2 (0.98 g, 0.004 mol) in a flask, and ethanol (5.04 ml) was added to NaBH 4 (0.15 g, 0.004 mol) in another flask to dissolve them. The mixture was placed in a 2-neck flask and stirred for about 5 minutes. Ethylenediamine (0.67 mL, 0.011 mol) and tetradec-3-yn-1-ol (5.04 g, 0.024 mol) were added to the mixed 2-neck flask, then hydrogen (H 2 ) was injected and incubated at room temperature for 5 hours. The reaction was carried out while stirring.
TLC로 반응의 진행정도를 확인하여 종료 후 셀라이트545(celite545)를 사용하여 에테르로 여과시켰다. 여과시킨 후 용매를 제거하고, 에테르/H2O/NaCl로 추출하고, 추출된 유기층을 세척 및 농축하고, 농축된 잔여물을 실리카겔 칼럼(hexane/ether:4/1)으로 정제하여 시스-테트라덱-3-엔-1-올(화합물 5)(4g, 78%)을 얻었다. The progress of the reaction was confirmed by TLC, and after completion, it was filtered with ether using Celite545. After filtration, the solvent was removed, extracted with ether/H 2 O/NaCl, the extracted organic layer was washed and concentrated, and the concentrated residue was purified using a silica gel column (hexane/ether:4/1) to obtain cis-tetra Dec-3-en-1-ol (Compound 5) (4g, 78%) was obtained.
시스-테트라덱-3-엔-1-올(화합물 5)의 NMR 분석결과는 다음과 같다:The NMR analysis results of cis-tetradec-3-en-1-ol (compound 5) are as follows:
1H NMR (CDCl3, 500MHz) δ 5.61-5.51 (m, 1H), 5.41-5.31 (m, 1H), 3.64 (t, J=6.5, 2H), 2.37-2.29 (m, 2H), 2.06 (qd, J=7.3, 1.6Hz, 2H), 1.38-1.29(m, 4H), 1.29-1.27(m, 4H), 1.27 (d, J=4.4Hz, 9H), 0.91-0.85 (m, 3H) ; 13C NMR (CDCl3, 126MHz) δ 133.57, 124.94, 62.36, 31.93, 30.83, 29.81-29.26 (m), 27.40, 22.70, 14.12 1H NMR (CDCl 3 , 500MHz) δ 5.61-5.51 (m, 1H), 5.41-5.31 (m, 1H), 3.64 (t, J =6.5, 2H), 2.37-2.29 (m, 2H), 2.06 ( qd, J =7.3, 1.6Hz, 2H), 1.38-1.29(m, 4H), 1.29-1.27(m, 4H), 1.27 (d, J =4.4Hz, 9H), 0.91-0.85 (m, 3H) ; 13 C NMR (CDCl 3 , 126 MHz) δ 133.57, 124.94, 62.36, 31.93, 30.83, 29.81-29.26 (m), 27.40, 22.70, 14.12
(ⅴ) 시스-테트라덱-3-엔-1-일 4-메틸벤젠술포네이트의 합성(v) Synthesis of cis-tetradec-3-en-1-yl 4-methylbenzenesulfonate
장치한 플라스크에 시스-테트라덱-3-엔-1-올(화합물5)(4g, 0.018mol)과 피리딘(24㎖)을 혼합하고 p-톨루엔술포닐 클로라이드(5.38g, 0.028mol)를 부가하였다. 실온에서 5시간 동안 교반하면서 반응시켰다. Cis-Tetradec-3-en-1-ol (Compound 5) (4 g, 0.018 mol) and pyridine (24 ml) were mixed in the equipped flask, and p-toluenesulfonyl chloride (5.38 g, 0.028 mol) was added. did. The reaction was stirred at room temperature for 5 hours.
TLC로 반응의 진행정도를 확인하고 반응이 종료되면 감압하여 용매를 제거하였다. 에테르/H2O/Na2SO4로 추출하고, 추출된 유기층을 세척 및 감압농축하고, 농축된 잔여물을 실리카겔 칼럼(hexane/EtOAC:9/1)으로 정제하여 시스-테트라덱-3-엔-1-일 4-메틸벤젠술포네이트(화합물 6)(6g, 87%)를 얻었다. The progress of the reaction was checked by TLC, and when the reaction was completed, the pressure was reduced to remove the solvent. Extracted with ether/H 2 O/Na 2 SO 4 , the extracted organic layer was washed and concentrated under reduced pressure, and the concentrated residue was purified using a silica gel column (hexane/EtOAC: 9/1) to produce cis-tetradec-3- En-1-yl 4-methylbenzenesulfonate (Compound 6) (6g, 87%) was obtained.
시스-테트라덱-3-엔-1-일 4-메틸벤젠술포네이트(화합물 6)의 NMR 분석결과는 다음과 같다:The NMR analysis results of cis-tetradec-3-en-1-yl 4-methylbenzenesulfonate (Compound 6) are as follows:
1H NMR (CDCl3, 500MHz) δ 7.82-7.76 (m, 2H), 7.37-7.31 (m, 2H), 5.52-5.43 (m, 1H), 5.26-5.17 (m, 1H), 4.00 (t, J=7.0H, 2H), 2.45 (s, 3H), 2.39 (qd, J=7.1, 1.5Hz, 2H), 1.95 (qd, J=7.2, 1.7Hz, 2H), 1.34-1.27(m, 3H), 1.25 (d, J=3.0Hz, 12H), 0.91-0.85 (m, 3H) ; 13C NMR (CDCl3, 126MHz) δ 144.65, 134.01, 133.30, 129.80, 127.95, 122.57, 69.81, 31.92, 29.72-29.19 (m), 27.32, 27.10, 22.69, 21.63, 14.12 1H NMR (CDCl 3 , 500MHz) δ 7.82-7.76 (m, 2H), 7.37-7.31 (m, 2H), 5.52-5.43 (m, 1H), 5.26-5.17 (m, 1H), 4.00 (t, J =7.0H, 2H), 2.45 (s, 3H), 2.39 (qd, J =7.1, 1.5Hz, 2H), 1.95 (qd, J =7.2, 1.7Hz, 2H), 1.34-1.27(m, 3H) ), 1.25 (d, J =3.0Hz, 12H), 0.91-0.85 (m, 3H) ; 13 C NMR (CDCl 3 , 126MHz) δ 144.65, 134.01, 133.30, 129.80, 127.95, 122.57, 69.81, 31.92, 29.72-29.19 (m), 27.32, 27.10, 22.69, 21 .63, 14.12
(ⅵ) 시스-2-메틸옥타덱-7-엔의 합성(vi) Synthesis of cis-2-methyloctadec-7-ene
2-넥 플라스크에 Mg(6g, 1.151mol)과 적당량의 I2을 넣어 가열교반기에 장치하고 다른 플라스크에는 1-브로모-3-메틸부탄(23.2g, 0.153mol)과 THF(72㎖)를 혼합하여 가열교반기에 장치된 플라스크에 혼합물을 서서히 가하면서 끓고 변색될 때까지 가열 및 교반하였다.Add Mg (6g, 1.151mol) and an appropriate amount of I 2 to a 2-neck flask and place it on a heating stirrer. 1-Bromo-3-methylbutane (23.2g, 0.153mol) and THF (72ml) were added to the other flask. The mixture was mixed and slowly added to a flask equipped with a heating stirrer, heated and stirred until it boiled and discolored.
이렇게 만들어진 그리냐르 시약을 시스-테트라덱-3-엔-1-일 4-메틸벤젠술포네이트(화합물 6)(6g, 0.016mol)와 THF(42㎖)를 혼합하여 -10℃로 유지시킨 플라스크에 서서히 부가하여 10분 동안 교반하였다. 교반 후 0.1M Li2CuCl4(1.98g, 0.0001mol)를 혼합하고 실온에서 3시간 동안 교반하면서 반응시켰다. The Grignard reagent thus prepared was mixed with cis-tetradec-3-en-1-yl 4-methylbenzenesulfonate (compound 6) (6 g, 0.016 mol) and THF (42 ml), and the flask was maintained at -10°C. It was slowly added and stirred for 10 minutes. After stirring, 0.1M Li 2 CuCl 4 (1.98 g, 0.0001 mol) was mixed and reacted with stirring for 3 hours at room temperature.
TLC로 반응의 진행정도를 확인하여 반응이 종료된 후 NH4Cl 수용액을 푸른빛이 될 때까지 부가하였다. 에틸에테르/NH4Cl/NaCl로 추출하고, 추출한 유기층을 세척하고 감압하여 농축하고, 농축된 잔여물을 실리카겔 칼럼(hexane 100%)으로 정제하여 시스-2-메틸옥타덱-7-엔(화합물 7)(3.91g, 48%)를 얻었다. The progress of the reaction was checked by TLC, and after the reaction was completed, NH 4 Cl aqueous solution was added until it turned blue. Extracted with ethyl ether/NH 4 Cl/NaCl, the extracted organic layer was washed and concentrated under reduced pressure, and the concentrated residue was purified using a silica gel column (hexane 100%) to produce cis-2-methyloctadec-7-ene (compound 7) (3.91g, 48%) was obtained.
시스-2-메틸옥타덱-7-엔(화합물 7)의 NMR 분석결과는 다음과 같다:The NMR analysis results of cis-2-methyloctadec-7-ene (compound 7) are as follows:
1H NMR (CDCl3, 500MHz) δ 5.35 (ddd, J=5.5, 4.4, 1.1 Hz, 2H), 2.06-1.98 (m, 4H), 1.51 (dqd, J=13.2, 6.6, 2.5 Hz, 2H), 1.37-1.31 (m, 3H), 1.31-1.22 (m, 22H), 1.21-1.11 (m, 4H), 0.87 (ddd, J=6.6, 5.3, 1.5Hz, 16H) ; 13C NMR (CDCl3, 126MHz) δ 129.91 (d, J=5.8Hz), 39.12, 38.93, 31.60, 30.05, 29.89-29.50 (m), 29.35 (d, J=4.3Hz), 27.99, 27.69, 27.34-27.01 (m), 22.79-22.56(m), 14.11 1H NMR (CDCl 3 , 500MHz) δ 5.35 (ddd, J =5.5, 4.4, 1.1 Hz, 2H), 2.06-1.98 (m, 4H), 1.51 (dqd, J =13.2, 6.6, 2.5 Hz, 2H) , 1.37-1.31 (m, 3H), 1.31-1.22 (m, 22H), 1.21-1.11 (m, 4H), 0.87 (ddd, J =6.6, 5.3, 1.5Hz, 16H) ; 13 C NMR (CDCl 3 , 126MHz) δ 129.91 (d, J =5.8Hz), 39.12, 38.93, 31.60, 30.05, 29.89-29.50 (m), 29.35 (d, J =4.3Hz), 27.99, 27.69, 27.34 -27.01 (m), 22.79-22.56(m), 14.11
(ⅶ) 시스-7,8-에폭시-2-메틸옥타데칸{(±)-Disparlure)}의 합성(vii) Synthesis of cis-7,8-epoxy-2-methyloctadecane {(±)-Disparlure)}
시스-2-메틸옥타덱-7-엔(화합물 7)(2g, 0.007 mol)에 메틸렌 클로라이드(52㎖)를 부가하여 10분 동안 교반하였다. 0℃로 온도를 설정하여 mCPBA(1.21g, 0.009mol)를 메틸렌 클로라이드(31.4㎖)와 같이 부가하여 실온에서 6시간 동안 교반하여 반응시켰다. Methylene chloride (52 ml) was added to cis-2-methyloctadec-7-ene (Compound 7) (2 g, 0.007 mol) and stirred for 10 minutes. The temperature was set to 0°C, mCPBA (1.21 g, 0.009 mol) was added together with methylene chloride (31.4 ml), and the mixture was stirred at room temperature for 6 hours to react.
TLC로 반응의 진행정도를 확인하고, 반응이 종료된 후 NaHCO3 수용액을 부가하여 10~20분 동안 교반하면서 NaHCO3가 부가된 상태 그대로 추출하였다. 추출 후 추출된 유기층을 세척하고 감압하여 농축하고, 농축된 잔여물을 실리카겔 칼럼(hexane/EtOAC:20/1)으로 정제하여 시스-7,8-에폭시-2-메틸옥타데칸{(±)-Disparlure)}(화합물 1)(0.4g, 38%)을 얻었다. The progress of the reaction was confirmed by TLC, and after the reaction was completed, NaHCO 3 aqueous solution was added, stirred for 10 to 20 minutes, and extracted as NaHCO 3 was added. After extraction, the extracted organic layer was washed and concentrated under reduced pressure, and the concentrated residue was purified using a silica gel column (hexane/EtOAC: 20/1) to produce cis-7,8-epoxy-2-methyloctadecane {(±)- Disparlure)} (Compound 1) (0.4g, 38%) was obtained.
시스-7,8-에폭시-2-메틸옥타데칸의 NMR 분석결과는 다음과 같다:The NMR analysis results of cis-7,8-epoxy-2-methyloctadecane are as follows:
1H NMR (CDCl3, 500MHz) δ 2.91 (td, J=4.6, 3.0Hz, 2H), 1.59-1.46 (m, 7H), 1.46 -1.37 (m, 3H), 1.36(d, J=7.8Hz, 3H) 1.32-1.25 (m, 12H), 1.19 (dt, J=10.7, 7.1 Hz, 2H), 0.88 (t, J=6.9Hz, 10H), ; 13C NMR (CDCl3, 126MHz) δ 57.25 (d, J=1.6Hz), 38.93, 31.92, 29.71-29.27 (m), 28.01-27.69(m), 27.34, 26.88, 26.62, 22.78-22.54 (m), 14.12 1 H NMR (CDCl 3 , 500MHz) δ 2.91 (td, J =4.6, 3.0Hz, 2H), 1.59-1.46 (m, 7H), 1.46 -1.37 (m, 3H), 1.36(d, J =7.8Hz) , 3H) 1.32-1.25 (m, 12H), 1.19 (dt, J =10.7, 7.1 Hz, 2H), 0.88 (t, J =6.9Hz, 10H), ; 13 C NMR (CDCl 3 , 126MHz) δ 57.25 (d, J =1.6Hz), 38.93, 31.92, 29.71-29.27 (m), 28.01-27.69 (m), 27.34, 26.88, 26.62, 22.78-22.54 (m) , 14.12
Claims (8)
(b) 테트라덱-3-인-1-올을 Ni(oAc)2 촉매 하에 부분 수소화 반응시켜 시스-테트라덱-3-엔-1-올을 합성하는 단계;
(c) 시스-테트라덱-3-엔-1-올의 -OH기를 토실레이트화 한 후 이소펜틸마그네슘 브로마이드로 그리냐르 반응시켜 시스-2-메틸옥타덱-7-엔을 합성하는 단계; 및
(d) 시스-2-메틸옥타덱-7-엔을 에폭시화 반응시켜 시스-7,8-에폭시-2-메틸옥타데칸을 합성하는 단계를 포함하는, 매미나방의 성페로몬인 시스-7,8-에폭시-2-메틸옥타데칸의 합성방법.(a) synthesizing tetradec-3-yn-1-ol by introducing a protecting group into the -OH group of 3-butynol, reacting it with 1-halodecane, and then removing the protecting group;
(b) synthesizing cis-tetradec-3-en-1-ol by partially hydrogenating tetradec-3-yn-1-ol under a Ni(oAc) 2 catalyst;
(c) synthesizing cis-2-methyloctadec-7-ene by tosylating the -OH group of cis-tetradec-3-en-1-ol and then subjecting it to Grignard reaction with isopentylmagnesium bromide; and
(d) cis-7, a sex pheromone of the gypsy moth, comprising the step of synthesizing cis-7,8-epoxy-2-methyloctadecane by epoxidizing cis-2-methyloctadec-7-ene, Method for synthesizing 8-epoxy-2-methyloctadecane.
상기 단계 (a)는, 3-부틴올의 -OH기에 보호기를 도입하고 1-브로모데칸과 반응시킨 후 보호기를 제거하여 테트라덱-3-인-1-올을 합성하는 것을 특징으로 하는, 매미나방의 성페로몬인 시스-7,8-에폭시-2-메틸옥타데칸의 합성방법.According to paragraph 1,
The step (a) is characterized in that tetradec-3-yn-1-ol is synthesized by introducing a protecting group into the -OH group of 3-butynol, reacting it with 1-bromodecane, and then removing the protecting group. Method for synthesizing cis-7,8-epoxy-2-methyloctadecane, the sex pheromone of the gypsy moth.
상기 단계 (a)는, 3-부틴올의 -OH기에 보호기로 -OTHP기를 도입하고 1-브로모데칸과 반응시킨 후 보호기를 제거하여 테트라덱-3-인-1-올을 합성하는 것을 특징으로 하는, 매미나방의 성페로몬인 시스-7,8-에폭시-2-메틸옥타데칸의 합성방법.According to paragraph 1,
Step (a) is characterized in that tetradec-3-yn-1-ol is synthesized by introducing -OTHP group as a protecting group to the -OH group of 3-butynol, reacting with 1-bromodecane, and then removing the protecting group. A method of synthesizing cis-7,8-epoxy-2-methyloctadecane, a gypsy moth sex pheromone.
상기 보호기를 제거하는 공정은,
상기 1-브로모데칸과의 반응으로 얻어진 2-(테트라덱-3-인-1-일옥시)테트라하이드로-2H-피란을 용매인 메탄올에 용해시키는 단계;
메탄올에 용해된 2-(테트라덱-3-인-1-일옥시)테트라하이드로-2H-피란과 p-톨루엔술폰산을 혼합하고 실온에서 3~6시간 동안 교반하면서 반응시키는 단계;
상기 용매를 제거하는 단계;
추출용매로 추출하는 단계;
추출된 유기층을 세척 및 농축하는 단계; 및
농축된 잔여물을 정제하는 단계를 포함하는 것을 특징으로 하는, 매미나방의 성페로몬인 시스-7,8-에폭시-2-메틸옥타데칸의 합성방법.According to paragraph 3,
The process of removing the protecting group is,
Dissolving 2-(tetradec-3-yn-1-yloxy)tetrahydro-2H-pyran obtained by reaction with 1-bromodecane in methanol as a solvent;
Mixing 2-(tetradec-3-yn-1-yloxy)tetrahydro-2H-pyran and p-toluenesulfonic acid dissolved in methanol and reacting with stirring for 3 to 6 hours at room temperature;
removing the solvent;
Extracting with an extraction solvent;
Washing and concentrating the extracted organic layer; and
A method for synthesizing cis-7,8-epoxy-2-methyloctadecane, a sex pheromone of gypsy moth, comprising the step of purifying the concentrated residue.
상기 단계 (b)는,
Ni(oAc)2와 NaBH4를 각각 용매 에탄올에 용해시키는 단계;
에탄올에 용해된 Ni(oAc)2와 NaBH4를 교반하면서 혼합하는 단계;
상기 혼합물에 에틸렌디아민과 테트라덱-3-인-1-올을 혼합하고 수소를 주입하여 실온에서 4~8시간 동안 교반하면서 반응시키는 단계;
상기 용매를 제거하는 단계;
추출용매로 추출하는 단계;
추출된 유기층을 세척 및 농축하는 단계; 및
농축된 잔여물을 정제하는 단계를 포함하는 것을 특징으로 하는, 매미나방의 성페로몬인 시스-7,8-에폭시-2-메틸옥타데칸의 합성방법.According to paragraph 1,
In step (b),
Dissolving Ni(oAc) 2 and NaBH 4 in the solvent ethanol, respectively;
Mixing Ni(oAc) 2 and NaBH 4 dissolved in ethanol while stirring;
Mixing ethylenediamine and tetradec-3-yn-1-ol in the mixture, injecting hydrogen and reacting with stirring at room temperature for 4 to 8 hours;
removing the solvent;
Extracting with an extraction solvent;
Washing and concentrating the extracted organic layer; and
A method for synthesizing cis-7,8-epoxy-2-methyloctadecane, a sex pheromone of gypsy moth, comprising the step of purifying the concentrated residue.
상기 단계 (c)는, 시스-테트라덱-3-엔-1-올을 p-톨루엔설포닐 클로라이드와 반응시켜 시스-테트라덱-3-엔-1-일 4-메틸벤젠술포네이트를 합성한 후, 이소펜틸마그네슘 브로마이드로 그리냐르 반응시켜 시스-2-메틸옥타덱-7-엔을 합성하는 것을 특징으로 하는, 매미나방의 성페로몬인 시스-7,8-에폭시-2-메틸옥타데칸의 합성방법.According to paragraph 1,
In step (c), cis-tetradec-3-en-1-ol is reacted with p-toluenesulfonyl chloride to synthesize cis-tetradec-3-en-1-yl 4-methylbenzenesulfonate. Afterwards, cis-2-methyloctadec-7-ene is synthesized through Grignard reaction with isopentylmagnesium bromide. Cis-7,8-epoxy-2-methyloctadecane, a sex pheromone of the gypsy moth, is Synthesis method.
상기 단계 (d)는, 시스-2-메틸옥타덱-7-엔을 mCPBA와 반응시켜 시스-7,8-에폭시-2-메틸옥타데칸을 합성하는 것을 특징으로 하는, 매미나방의 성페로몬인 시스-7,8-에폭시-2-메틸옥타데칸의 합성방법.According to paragraph 1,
The step (d) is a sex pheromone of the gypsy moth, characterized in that cis-7,8-epoxy-2-methyloctadecane is synthesized by reacting cis-2-methyloctadec-7-ene with mCPBA. Method for synthesizing cis-7,8-epoxy-2-methyloctadecane.
상기 단계 (d)는,
시스-2-메틸옥타덱-7-엔과 메틸렌 클로라이드를 8~15분 동안 교반하면서 반응시키는 단계;
이어서 0℃에서 mCPBA와 메틸렌 클로라이드를 가하고 실온에서 4~8시간 동안 교반하면서 반응시키는 단계;
이어서 NaHCO3(탄산수소나트륨) 수용액을 가하여 10~20분 동안 교반하는 단계;
이어서 NaHCO3 수용액이 부가된 상태로 추출하는 단계;
상기 추출된 유기층을 세척 및 농축하는 단계; 및
상기 농축으로 얻어진 농축물을 정제하는 단계를 포함하는 것을 특징으로 하는, 매미나방의 성페로몬인 시스-7,8-에폭시-2-메틸옥타데칸의 합성방법.
According to paragraph 1,
In step (d),
Reacting cis-2-methyloctadec-7-ene and methylene chloride with stirring for 8 to 15 minutes;
Next, adding mCPBA and methylene chloride at 0°C and reacting with stirring at room temperature for 4 to 8 hours;
Next, adding NaHCO 3 (sodium bicarbonate) aqueous solution and stirring for 10 to 20 minutes;
Next, extraction with NaHCO 3 aqueous solution added;
Washing and concentrating the extracted organic layer; and
A method for synthesizing cis-7,8-epoxy-2-methyloctadecane, a sex pheromone of gypsy moth, comprising the step of purifying the concentrate obtained by the concentration.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020220112069A KR102659019B1 (en) | 2022-09-05 | 2022-09-05 | Synthesis method of sex pheromon cis-7,8-epoxy-2-methyloctadecane in Lymantria dispar |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020220112069A KR102659019B1 (en) | 2022-09-05 | 2022-09-05 | Synthesis method of sex pheromon cis-7,8-epoxy-2-methyloctadecane in Lymantria dispar |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20240033428A KR20240033428A (en) | 2024-03-12 |
KR102659019B1 true KR102659019B1 (en) | 2024-04-19 |
Family
ID=90299819
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020220112069A KR102659019B1 (en) | 2022-09-05 | 2022-09-05 | Synthesis method of sex pheromon cis-7,8-epoxy-2-methyloctadecane in Lymantria dispar |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR102659019B1 (en) |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5463149A (en) | 1993-07-20 | 1995-10-31 | Shin-Etsu Chemical Co., Ltd. | 1-halo-cis-3-tetradecenes and processes for the preparation of cis-olefin compounds by using same |
US20130231499A1 (en) | 2012-03-05 | 2013-09-05 | California Institute Of Technology | Synthesis of z-olefin-containing lepidopteran insect pheromones |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101109375B1 (en) | 2009-06-17 | 2012-01-30 | 경기대학교 산학협력단 | Synthesis method of +-disparlure, its enantiomer and trans-isomer |
KR102513022B1 (en) | 2020-11-30 | 2023-03-22 | 경북대학교 산학협력단 | Method for producing (+)-disparure using L-(+)-tartaric acid |
-
2022
- 2022-09-05 KR KR1020220112069A patent/KR102659019B1/en active IP Right Grant
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5463149A (en) | 1993-07-20 | 1995-10-31 | Shin-Etsu Chemical Co., Ltd. | 1-halo-cis-3-tetradecenes and processes for the preparation of cis-olefin compounds by using same |
US20130231499A1 (en) | 2012-03-05 | 2013-09-05 | California Institute Of Technology | Synthesis of z-olefin-containing lepidopteran insect pheromones |
Non-Patent Citations (2)
Title |
---|
Gries et al., Journal of Chemical Ecology, Vol. 31, 2005, pp. 49-62. |
Markgraf et al., Journal of Chemical Ecology, Vol. 9, 1983, pp. 211-218. |
Also Published As
Publication number | Publication date |
---|---|
KR20240033428A (en) | 2024-03-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP3782051B2 (en) | Method for producing meso-zeaxanthin | |
CN111217729A (en) | Preparation method and application of clethodim intermediate | |
CN110845447A (en) | Method for synthesizing sex pheromone component of fall webworm | |
Millar et al. | Synthesis and field testing of enantiomers of 6Z, 9Z-cis-3, 4-epoxydienes as sex attractants for geometrid moths: interactions of enantiomers and regioisomers | |
KR102659019B1 (en) | Synthesis method of sex pheromon cis-7,8-epoxy-2-methyloctadecane in Lymantria dispar | |
KR101901808B1 (en) | Method for preparation of Octadecadienyl acetate as major sex pheromone of cherry tree borer, Synanthedon bicingulate | |
CN110981793B (en) | Synthetic method of 2- (difluoromethyl) pyridine-3-alcohol | |
CN109053637B (en) | Synthetic method of inchworm sex pheromone and intermediate thereof | |
CN108864019B (en) | Method for synthesizing sex pheromone compound of litchi pedicellus moth | |
Yasumoto et al. | Isolation and absolute configuration determination of aliphatic sulfates as the Daphnia kairomones inducing morphological defense of a phytoplankton—Part 2 | |
CN110724042A (en) | Method for synthesizing sex pheromone active ingredient of populus canula | |
CN103087060B (en) | High activity paichongding isomer and preparation method thereof | |
CN114605265A (en) | Demodex and synthetic method thereof | |
CN109678662B (en) | Synthesis method of acetic acid 7E, 9Z-dodecadienyl ester | |
Zhang et al. | Synthesis and field test of three candidates for soybean pod borer's sex pheromone | |
Kumar et al. | Synthesis of Sex Pheromones of the Citrus Leafminer (CLM)(Phyllocnistis citrella) | |
CN109699646B (en) | Preparation method of rice stem borer pheromone component | |
CN116354850B (en) | Preparation method of fenpropathrin | |
CN110105311A (en) | A kind of synthetic method of fall webworm sex pheromone intermediate | |
KR20230118397A (en) | Producing method of sex pheromon (Z)-9-tetradecenyl acetate in Spodoptera frugiperda | |
CN115043737B (en) | Tetrahydrolinalool secondary amine compound, preparation method and weeding application thereof | |
CN108191655B (en) | Synthetic method and application of American western corn rootworm sex pheromone | |
CN109369573B (en) | Preparation method of sex pheromone intermediate of fall webworm | |
CN115490589B (en) | Synthesis method of sex attractant for potato tuber moth | |
Tseng et al. | Improved practical synthesis of the sex pheromone of female sweet potato weevil, Cylas formicarius |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant |